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Abstract 
The circulating renin-angiotensin system (RAS) has been known to play an 
important role in the maintenance of blood pressure, electrolyte and fluid 
homeostasis. However, the expression, fimction and regulation of RAS in the carotid 
body remain undefined. 
In the present study, the existence of functional angiotensin II (Ang II) 
receptors were demonstrated in the type I cells of the carotid body. 
Spectrofluorimetric measurement showed that Ang II (10-100 nM) concentration-
dependently increased cyotsolic free [Ca^"! ([Ca '^^ O in type I cells. The 
response was blocked by pretreatment with losartan (1 )uM), an ATi receptor 
antagonist, but not by blockade of AT2 receptors with PD-123319 (1 )liM). Moreover, 
the mRNA expression of ATi receptors, both ATiaand ATib subtypes, were detected 
by RT-PCR in the carotid body. In addition, immunohistochemical study revealed 
that ATi immimoreactivity was localized in lobules of type I cell in rat carotid body. 
These data suggest that type I cells in the rat carotid body express functional Ang II 
receptors. The binding of Ang II to the Ang II receptors increases [Ca2+]i’ a key step 
of the intracellular signaling cascade following the activation of the receptors. 
In addition, the effect of chronic hypoxia on the expression and the 
localization of Ang II receptors were investigated by RT-PCR, 
immunohistochemistry and in-vitro electrophysiology. Results from RT-PCR 
revealed that chronic hypoxia exhibited differential effects on the gene expression of 
Ang II receptors, namely ATi and AT2，in the carotid body. The mRNA expression 
for subtypes of the ATi receptor, ATia and ATib, was significantly increased in the 
carotid body with chronic hypoxia. Results from immunohistochemical study 
showed that ATi receptor immimoreactivity was found in lobules of glomus cells in 
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the carotid body and the immunoreactivity was more intense in chronic hypoxia than 
in normoxic controls. In-vitro electrophysiological studies consistently demonstrated 
that chronic hypoxia enhanced the ATi receptor-mediated excitation of carotid body 
chemoreceptor activity. These data suggest that chronic hypoxia upregulates the 
transcriptional and post-transcriptional expression of ATi receptors in rat carotid 
body. The upregulation of the expression also enhances ATi receptor-mediated 
excitation of the carotid body afferent activity. 
Furthermore, the expression and localization of angiotensinogen (AGT), the 
obligatory component for a locally generated angiotensin system, has been 
demonstrated in rat carotid body using molecular biological and 
immunohistochemical approaches. In-situ hybridization showed the expression of 
AGT within the glomus cells of rat carotid body. Double immunostaining of AGT 
and tyrosine hydroxylase, an immunohistochemical marker for type I glomus cells, 
elucidated that AGT protein was specially localized to the lobules of type I cells. 
Consistently, RT-PCR and Western blot analyses confirmed the expression of AGT 
mRNA and protein respectively in the carotid body. However, renin mRNA was not 
detected using RT-PCR and Northern blot analyses whereas angiotensin converting 
enzyme (ACE) mRNA was detected in the carotid body. These data support the 
existence of a locally generated angiotensin system in the carotid body, which might 
be linked to a renin-independent biosynthetic pathway. 
In a similar manner, the changes in the expression and activity of AGT and 
ACE in the carotid body under hypoxic condition was also investigated using 
molecular biological approaches and specific assay of ACE activity. Results from 
RT-PCR showed that both AGT and ACE gene transcripts in the carotid body were 
upregulated by chronic hypoxia. In-situ hybridization demonstrated that the 
ii 
upregulation of the expression of AGT mRNA was found within the glomus cells of 
rat carotid body. Western blot analysis further demonstrated the upregulation effect 
of chronic hypoxia on AGT protein in rat carotid body. At the same time, the 
activity of ACE in rat carotid body of time-course hypoxic treatment was also 
upregulated by chronic hypoxia. These data suggest that chronic hypoxia 
upregulates expression of the major components, which are AGT and ACE, of the 
locally angiotensin-generating system in rat carotid body. Interestingly, there were 
also specific AT4 receptors found in the rat carotid body, which were also subjected 
to be upregulated by chronic hypoxia. The upregulation of the expression of these 
RAS components may be of physiological and clinical relevance. 
In conclusion, results obtained from the expression and regulation studies, 
and functional analyses suggest that the ATi receptor regulates the excitability of the 
carotid chemoreceptors. Hence Ang II elevates the intracellular calcium level of 
glomus cells and the carotid afferent activity that activates the chemoreflex pathway. 
This could be essential for the physiological response to hypoxia and the 
maintenance of salt and water balance. Chronic hypoxia is associated with an 
enhanced sensitivity of the chemoreceptor activities to Ang II via an upregulation of 
ATi receptor expression. In addition, evidence for the existence of an intrinsic 
angiotensin system was demonstrated in the carotid body, which was subjected to the 
regulation by chronic hypoxia. Taken together, the modulation of RAS may be 
important for the adaptation of the carotid body functions in the hypoxic ventilatory 
response, for purpose of enhancing the cardiorespiratory response and adjusting for 
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Angiotensin converting enzyme 血管緊張素轉化酵素 
Angiotensin receptor 血管緊張素受體 
Carotid body 頸動_ 
Chemoreceptor 化學感應器 
Chronic hypoxia 慢性缺氧 
Circulating renin-angiotensin system 循環腎素-血管緊張素系統 
In-situ hybridization 原位雜交 
In-vitro electrophysiology 體夕f 電生理學 
Locally generated angiotensin system 局部血管緊張素系統 
Type I glomus cells 第一類IW絡細胞 
Tyrosine hydroxylase 酪氨酸輕化酶 
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Chapter 1 Introduction 
1.1 Overview of Carotid Body 
The carotid body was first described by a Swiss physiologist, Albrecht von 
Haller, in 1743. It is a small, oval, reddish-brown organ located near the bifurication of 
the common carotid artery on its posteromedial wall. It may be associated with any of 
the arteries arising from the general area of the carotid bifurcation, which are the internal 
carotid, the external carotid and the occipital or ascending pharyngeal, depending upon 
species [Ross, 1959; Biscoe, 1971] (Fig 1-1). The normal carotid body in human 
measures 3-5 mm in diameter but is often larger in people living in higher altitudes 
[Arias-Stella, 1969]. Whilst, normal carotid body in rat measures 0.1-1 mm in diameter 
only. 
The mammalian carotid body is invested with a collagenous capsule，which 
varies in thickness, depending upon the species being studied. In light microscopic 
sections, the carotid body is seen to consist of groups of cells sited in a highly vascular 
connective tissue stroma where the individual cell groups are being separated by 
variable amounts of connective tissue [Fallot, 1987]. Since the amount of connective 
tissue is species-variable and age-dependable, some species such as rat and cat possess a 
compact, discrete carotid body whilst other species such as rabbit and adult sheep 
possess a rather diffuse organ [McDonald, 1981]. 
As mentioned above, the cellular structure of the carotid body at the level of light 
microscope shows lobules of glomic tissue where two distinct cell types, namely the 
Type I cells and the Type II cells, can be distinguished on the basis of nuclear staining 
pattern and morphology [Gomez, 1908; Bee and Howard, 1993] (Fig. 1-2). One cell 
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Figure 1-1 Diagrammatic representation of the carotid sinus, the carotid body and 
their innervation [Beme et al , 1998]. 
Figure 1-2 Cellular structure of the carotid body at the level of light microscope 
shows lobules of glomic tissue where two distinct cell types, namely 
Type I cells (inside circle) and Type II cells (inside rectangle) are 
identified, as distinguished by their spherical and elongated nuclei 
respectively. BV, Blood vessel. 
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type possesses a strongly basophilic nucleus and is rather elongated in shape, whilst the 
other is more spherical and has a less basophilic nucleus. 
1.1.1 Type I Cells 
The Type I (chief) cells are the most abundant of the specific cells within the 
carotid body, and it is estimated that in the adult rat there are 11,500 土 2，500 (mean 土 
SD) cells per organ [McDonald and Mitchell, 1975]. The Type I cells are arranged in 
small spherical or cylindrical anastomosing cords and are entangled in a skein of 
interlacing nerve fibres and fine capillary branches (Fig 1-2). The cell bodies of the 
Type I cell are large, about 10-15 \im, and apparently round, oval or polygonal in shape 
with a large round nucleus [Fallot, 1987]. 
Using electron microscopy, the contents of the Type I cell body is resolved. 
Mitochondria are plentiful within the Type I cells and randomly distributed in the 
cytoplasm of the cell body. The Golgi apparatus is sometimes prominent and found in 
the typical juxtanuclear position. The rough endoplasmic reticulum is well developed 
and frequently orientated in parallel arrays reminiscent of Nissel substance in neurons 
[Al-Lami, 1964]. The most striking and unique feature of Type I cells is the presence of 
electron dense-cored vesicles within the cytoplasm [Lever and Boyd, 1957]. Their 
number and distribution within the cell vary greatly from cell to cell and from area to 
area. The electron dense-cored vesicles measure 2,000-20,000 nm in diameter and are 
spherical in shape, each consisting of a core of variable electron density surrounded by a 
lighter clear zone and encased by a single trilaminar membrane [Al-Lami, 1964; Biscoe, 
1971]. 
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The Type I cells are associated with catecholamine storage; both noradrenaline 
and dopamine [Bee and Howard, 1993]. Furthermore, the Type I cells are divided into 
three subtypes [Smith et al.，1982; Smith et al.，1984]. The commonest subtype is the 
light cell, characterized by a large euchromatic nucleus; the second subtype, the dark cell, 
has a large haematoxophilic nucleus, whilst the third subtype, the pyknotic cell, has a 
small pyknotic nucleus. Groups of the Type I cells are often separated from the 
capillary wall by processes of the second variety of cells, the Type II cells. 
1.1.2 Type II Cells 
The Type II (sustentacula!) cells are identified by their position and by their 
elongated basophilic nuclei (Fig. 1-2). They enclose unmyelinated nerve fibres and 
partially encircle nests of Type I cells. Similar to Type I cells. Type II cells themselves 
contain the usual cytoplasmic inclusions; Golgi apparatus, endoplasmic reticulum and 
mitochondria [Biscoe, 1971]. Like Schwann cells, from which it is difficult to 
distinguish them, Type II cells ensheath nerve fibres and respond to denervation of the 
carotid body [Bee and Howard, 1993], The first indication of degeneration in the carotid 
body was that nerve endings became separated from Type I cell membrane by processes 
of Type II cells suggested their ability of phagocytosis of debris from degenerated nerve 
endings [McDonald and Mitchell, 1975]. However, despite the documentations up-to-
date，little is known about the Type II cells. The functional relationship of which within 
the carotid body is still unclear and further efforts should be made to better understand 
these cells. 
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1.1.3 Blood Vessels 
It is indicated that about 25% of the total volume of the carotid body is composed 
of blood vessels. Blood is supplied to the carotid body from one or more glomic arteries, 
arising from the bifurcation or branches of the carotid artery. In proportion to its weight, 
the carotid body has a gigantic blood flow of about 2,000 ml/g wet weight per minute 
[Daly et al., 1954; Keller and Lubbers, 1972]. This is greater per gram of tissue than any 
other organs, such as brain (60 ml/min per lOOg wet weight) [Dumke and Schmidt, 1943] 
and heart (64-150 ml/100 kg wet weight per minute) [Gregg, 1950]. It is suggested that 
oxygen consumption is some 70% greater within the carotid body than that in the 
cerebral cortex. Two types of capillaries, both with fenestrated endothelium, are present 
in the carotid body [McDonald et al., 1988]. Type I capillaries penetrate the clusters of 
Type I cells; they are irregular in shape, of variable diameter and have many venous 
connections. Their precapillary sphincters serve as a gate in order to regulate perfusion 
of the glomic tissue. Type II capillaries are much smaller, bypass the lobules and have 
only one or two venous connections. The vessels within the carotid body have both 
parasympathetic and sympathetic innervation and flow may be autoregulated [Bee and 
Howard, 1993]. 
1.1.4 Innervation 
The most outstanding contribution to the study of carotid body innervation was 
the studies of methylene blue and silver stain preparations made by de Castro [de Castro, 
1926; de Castro, 1928]. He showed that single nerve fibres branched to innervate a 
number of cells within the carotid body and that the nerve terminals were of variable 
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shapes. The innervation of the carotid body is sensory, parasympathetic and 
sympathetic and is innervated by the ninth cranial, glossopharyngeal nerve (Fig. 1-1). 
Within the carotid sinus nerve, which is a branch from the ninth cranial, 
glossopharyngeal nerve, supplying the carotid body are parasympathetic fibres and 
myelinated sensory fibres, terminating on Type I cells. In addition, there is an 
unmyelinated supply that appears to innervate the Type II cells [Bee and Howard, 1993]. 
The sympathetic innervation is supplied from the superior cervical ganglion via the 
ganglioglomerula nerve [Bee and Howard, 1993]. Majority of these fibres supply the 
vasculature and apparently maintain a degree of tone that intimates an active regulation 
of blood flow through the carotid body as mentioned above. 
1.1.5 Biochemistry 
The carotid body contains a vast range of amines and peptides that shows a 
heterogeneous distribution within the cells [Smith et al , 1990]. The functions of some 
of which have been studied. For example, dopamine is stored in the dense-cored 
vesicles of the Type I cells and inhibit carotid chemoreceptor activity through a D： 
receptor even in a low dosage [Mir et al.，1984; McQueen, 1984]. Blockage of this D2 
receptor by specific antagonist can raise spontaneous neural activity and thus enhancing 
ventilation. Other agents, such as opiate peptides (e.g. met-enkephalin) and the 
tachykinins (e.g. substance P and neurokinin A) have an inhibition and enhancement 
effect of carotid sinus nerve discharge respectively [McQueen, 1980; McQueen and 
Ribeiro, 1980; Prabhaker et al., 1989]. 
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1.1.6 Physiology and Function 
The carotid body is a peripheral arterial chemoreceptor, which plays a central 
role in cardiorespiratory responses to physiological stimuli such as change in arterial 
blood gases, pH, or osmolality. The only other major paraganglia with analogous 
chemoreceptor function are the aortic bodies. Type I cells in the carotid body are 
believed to be the receptor cells for peripheral chemoreception and their activity is 
associated intimately with the The elevation of may be coupled to the 
vesicular secretion of catecholamines and is believed to be an important step for 
chemotransduction [Gonzalez et al., 1994]. Type I cells of the carotid body are 
stimulated by hypoxia, hypercapnia, or decreasing pH. The stimulations would initiate 
an autonomic reflex, which leads to an increase in the respiratory rate and depth; the 
activation of the sympathetic nervous system, such as an increase in heart rate，systemic 
vascular tone and blood pressure; and the activation of the cerebral cortical activity [Bee 
and Howard, 1993]. Besides, the carotid body is also stimulated by other stimulants 
such as increased blood temperature and certain chemicals (e.g. cyanide and nicotine). 
It is this close association with respiratory drive and the sympathetic nervous 
system response that have prompted investigation of the carotid body's role in disease 
processes such as chronic lung disease (e.g. chronic obstructive pulmonary disease， 
chronic bronchitis and emphysema), obstructive sleep apnea and sudden infant death 
syndrome. Nonetheless, there is also evidence for the carotid body's reflex influence on 
systems other than ventilatory drive, such as the pulmonary circulation [Szidon and Flint, 
1977; Naeije et al.，1989] and the kidney [Honig, 1983], indicating the significance of 
the organ. 
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1.2 The Renin-Angiotensin System (RAS) 
The existence of the RAS was first reported in 1898 when Tigerstedt and 
Bergman observed that intravenous injections of rabbit kidney extracts resulted in a 
significant and sustained increase in blood pressure [Tigerstedt and Bergman, 1898]. 
The unknown active component was named renin, which was subsequently shown to be 
a protease enzyme that catalyzes the production of a secondary precursor substance 
[Kohlstaedt et al.，1938]. This secondary precursor substance and the substrate for this 
precursor substance were identified simultaneously as angiotensin and angiotensinogen 
[Page and Helmer, 1940; Braun-Menendez et al.，1940]. 
1.2.1 Circulating RAS 
The systemic or circulating renin-angiotensin system (RAS) is known to play an 
important role in the regulation of blood pressure, fluid and electrolyte homeostasis 
[Peach, 1977]. It is an endocrine system for the production of angiotensin in plasma 
through the systemic circulation [Catt et al., 1970; Vane, 1974� .The concept of the 
circulating RAS can be summarized as follows: angiotensinogen, which is produced in 
the liver, generates the relatively inactive decapiptide, angiotensin I (Ang I), by the 
action of the kidney-derived renin in circulating blood. Ang I is then converted by the 
lung-derived angiotensin converting enzyme (ACE) to the biologically active 
octapeptide, angiotensin II (Ang II). Ang II is subsequently conveyed via arterial blood 
to its receptors in peripheral tissues where corresponding physiological actions will take 
place (Fig. 1-3). 
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Figure 1-3 Multiple pathways of angiotensin production and biochemistry of major 
RAS components. R = remaining of the amino acids sequences. 
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1.2.1.1 Angiotensinogen 
Angiotensinogen (AGT) is the only precursor of the angiotensin peptides and the 
limiting factor in the enzymatic reaction of renin. It is a 55- to 60-kDa glycoprotein 
mainly synthesized in the liver [Page et al., 1941] and is nominally 477 amino acids with 
a signal sequence of 24 amino acids in rodents [Ohkubo et al, 1983; Clouston et al., 
1988]. Two different forms of angiotensinogen as examined by isoelectric focusing in 
rat plasma are released [Murakami et al.，1984]. The relatively low-molecular-weight 
form is the major component of the circulating plasma angiotensinogen, whereas the 
larger form was found to exist at a higher plasma level during the last trimester of 
pregnancy [Tewsbury and Dart, 1982]. 
Angiotensinogen is introduced to the circulatory system to become associated 
with the arglobulin, arglobulin or albumin fraction of plasma on the species-specific 
basis [Plentl et al.，1943]. The plasma angiotensinogen concentration varies from species 
to species and is about 0.8 to 1.0 ^M in human, 0.3-0.5 _ in rat and 0.5-0.7 ^M in 
rabbit [Reid et al, 1978]. Its concentration increased after treatment of 
adrenocorticotrophic hormone (ACTH), estrogen and adrenal cortical hormones [Reid et 
al.，1973; Helmer and Griffith, 1952] and decreased after hypatectomy, adrenalectomy 
and hypophysectomy [Hasegawa et al , 1973; Reid et al., 1973]. 
1.2.1.2 Renin 
Renin is an aspartyl protease that cleaves angiotensinogen peptide to form a 10 
amino acids peptide Ang I (Fig. 1-3). The nucleotide sequence of the genome of renin 
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has 10 exons in human but 9 in rat and mouse [Hardman et al., 1984; Hobart et al.’ 
1984]. A high degree of sequence identity was found among the three renal renins. 
There are two forms of renin found _ active and inactive. Active renin is able to 
convert angiotensinogen to Ang I whereas inactive renins, namely preprorenin and 
prorenin, are the precursor of active renin and were found in circulating blood plasma, 
amniotic fluid and kidney [Lumber, 1971; Nielsen and Poulsen, 1988; Day and 
Luetscher, 1975]. It is suggested that preprorenin and prorenin can be modified by the 
action of trypsin or acidification to yield active renin (Fig. 1-3). The findings of 
cathepsin G，a renin-activating enzyme, in platelets and neutrophils, and a renin-bound 
protein in renal tubules of rat further support the interconversion of inactive and active 
renin forms [Dzau, 1984a; Ikemoto et al., 1982]. 
The afferent arteriolar juxtaglomerular cells of kidney act as the gene production 
site for renin in the endocrine system [Cook, 1971]. The preprorenin synthesized in 
cytoplasm is rapidly internalized into rough endoplasmic reticulum and hydrolyzed by 
signal protease to give prorenin. The prorenin is then converted to active renin in Golgi 
apparatus and is secreted through exocytosis under cellular regulation [Pratt et al., 1983]. 
Expression of renin gene is found to be tissue-specific as renin gene was observed in 
mouse, but not rat, submandibular glands [Morris et al , 1980]. 
1.2.1.3 Angiotensin I 
Angiotensin I (Ang I) is a decapeptide (i.e. consists of 10 amino acids residues) 
that cleaved from the N-terminus of angiotensinogen by renin (Fig. 1-3). This 
decapeptide is considered the inactive precursor of the biologically active Ang II. In 
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human, it attaches to the N-terminus by Leu-Val bond, whereas by Leu-Leu bond in rat 
[Tewksbury et al., 1981]. 
1.2.1.4 Angiotensin Converting Enzyme 
Angiotensin converting enzyme (ACE) is a dipeptidyl carboxyl peptidase, which 
is a membrane-bound ectoenzyme. It cleaves Ang I at His-Leu dipeptidyl residue from 
the carboxyl terminal to form the biologically active peptide, Ang II (Fig. 1-3). These 
actions take place in the lung [Ng and Vane, 1967] where the large total surface area of 
the whole pulmonary vasculature facilitates the rapid conversion process and makes it 
accessible to circulating macromolecules. ACE is also produced in other sites such as 
the kidney, liver and systemic vascular bed, but to a lesser extent. Since ACE is a 
membrane-bound peptidase with a zinc ectoenzyme facing the lumen, conversion of 
Ang II occurs extracellularly in the lungs. There are also a number of dipeptide bonds 
and tripeptide bonds cleaved by ACE, like bradykinin, metenkephalin, substance P and 
luteinizing hormone releasing hormone. 
1.2.1.5 Angiotensin II 
Angiotensin 11 (Ang II) is an octapeptide (i.e. consists of 8 amino acids residues) 
that acts as the biologically active component of the RAS (Fig. 1-3). It exhibits a wide 
spectrum of biological actions including body fluid balance, cardiovascular homeostasis 
and growth promotion in relation to angiogenesis and cardiotrophy [Allen et al.，1988]. 
Ang II plays a pivotal role in the regulation of body fluid homeostasis. It is 
found that the level of plasma Ang II rises immediately when renin is released in 
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response to the decrease of blood volume [Tobian et al.，1959; Skinner et al., 1963]. The 
ability of Ang II to (1) induce thirst and sodium appetite; (2) enhance the intestinal 
absorption of water and sodium ions; and (3) reduce renal excretion of water and sodium 
ions show that Ang II could increase the blood volume back to normal in an 
accumulative fashion. 
Based on the findings that Ang II stimulates transepithelial fluid and electrolyte 
transport in rat intestine [Levens et al., 1981; Bolton et al.，1975]; stimulates medullary 
catecholamine secretion [Peach, 1971]; modulates the releases of several pituitary 
hormones including luteinizing hormone, prolactin, ACTH, growth hormone and 
vasopressin [Steele et al.，1982a, 1982b, 1983]; stimulates prostagulandin release and 
affects intracellular calcium and phospahatidyl inositol phosphate metabolism [Smith et 
al., 1984], the actions of Ang II are concluded to be rapid-acting but short-lasting, 
suggesting its role in response to sudden changes in the internal or external environment 
by initiating some physiological reactions in order to restore the normal status. 
1.2.1.6 Angiotensin II Receptors 
Pharmacological inhibition of Ang II receptors was first achieved in 1971 with 
the discovery of saralasin, the first specific peptide antagonist of Ang II. The subsequent 
development of nonpeptide Ang II antagonists have allowed the identification of at least 
two distinct Ang II receptors subtypes, named ATi and AT� receptors [Catt and Abbott 
1991; Timmermans et al.，1991] based on their affinity: Type 1 receptor (ATi) can be 
blocked by losartan and Dup 753 while type 2 (AT2) receptor shows affinity to 
PD123179 and CG42112A [Chiu et al., 1989; Bumpus et al.，1991]. Results showed 
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that most of the major known functions of Ang II，such as stimulation of aldosterone and 
norepinephrine release, and pressor and tachycardic response could be inhibited by 
losartan, but not by PD123179. Thus, it was suggested that ATi receptor was the one 
that mediates the major physiological functions of Ang II. AT! receptors localize 
predominantly in the vascular smooth muscle，whereas AT2 receptors are found to be 
present in the adrenal medulla and uterus. However, both ATi and AT2 receptors are 
found in the adrenal cortex, kidney and brain [Timmermans et al , 1991]. 
ATi receptor is further divided into two subtypes according to their signal 
transduction systems: ATia receptor is coupled to Gq-type GTP-binding protein while 
ATib receptor is coupled to Grtype GTP-binding protein [Catt and Abbott, 1991]. Rat 
ATi receptor consists of 359 amino acids residues and contains three potential N-
glycosylation sites; one in the hydrophobic N-terminal extracellular region and the other 
two in the third extracellular loop. The two ATi receptor subtypes have about 96% 
sequence homology at the nucleotide levels. The ATj, receptor is localized on rat 
genomic chromosome 17 while ATib receptor on rat chromosome 2 [Lewis et al., 1993]. 
These two subtypes are expressed in various target tissue in different proportions [Kakar 
et al.，1992]. Although some studies found no difference in ligand binding affinity 
between the two subtypes [Sasamura et al.，1992], others suggested that they exhibit 
different ligand binding affinity [Miura and Kamik, 1999]. 
The cDNA of rat AT2 receptor encodes 363 amino acids residues and has 
approximately 30% sequence identity with that of AT丨 receptor. Northern Blot analysis 
showed that the expression of AT2 in fetuses is more abundant than that in adults, 
suggesting that AT2 may play a more significant role in growth and development. 
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The ATi and AT2 receptors appear to be coupled to different signal transduction 
pathways. It is now generally accepted that Ang II receptors are coupled via a G-protein 
to phosphoinositide-specific phospholipase C (PLC), which catalyzes the formation of 
inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) from phosphatidylinositol-4, 
5-bisphosphate (IP2) [Carbonell et al.，1998; Ito et al.，1991]. Activation of ATi 
receptors in cell results in a rapid transient increase in intracellular calcium, followed by 
a plateau phase that slowly returns to baseline. Much less is known regarding the 
mechanism coupled to the AT2 receptor. However, it is clear that this receptor does not 
appear to function via the classical signal transduction pathways. 
1.2.1.7 Angiotensin IV and Angiotensin IV Receptor 
Angiotensin IV (Ang IV) is the 3-8 hexapeptide (Val-Tyr-Ile-His-Pro-Phe) 
fragment of Ang II from the C-teraiinal. Since Ang IV does not display any of the Ang 
II biological effect nor does it bind with high affinity to either of the Ang II receptor 
subtypes, the ATi and AT2 receptors, it was considered to be a biologically inactive 
metabolite of Ang II [Swanson et al.，1992]. However, it is now established that Ang IV 
binds to a unique binding site, the angiotensin IV receptor, namely AT4 receptor, to 
produce certain biological effects that were not previously associated with the RAS. 
The AT4 receptor is highly specific for Ang IV and does not bind to ATi or AT2 
receptor agonists or antagonists with high affinity. As the AT4 receptor has not been 
cloned nor sequenced, the structure of which has not been determined yet. AT4 
receptors are found to localized in kidney, adrenal gland, heart, vascular endothelial and 
smooth muscle cells, lung, bladder, brain, spinal cord and prostate in several species 
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[Coleman et al.，1998a]. In the kidney, AT4 receptors are specifically localized to the 
outer strip of the outer medulla and at lower level over the entire kidney cortex [Harding 
et al.，1994; Handa et al.，1998]. The receptors are further found localized to the 
microvilli and cell bodies of the convoluted proximal tubules [Handa et al., 1998]. 
Since Ang IV is localized in multiple target organs, it has a diverse array of 
possible functions. It was found that Ang IV binds to AT4 receptors in kidney, 
vasculature and cerebral cortex to facilitate vasodilatation via a nitric oxide-dependent 
pathway [Coleman et al., 1998b; Haberl et al., 1991; Kramar et al, 1998]. In addition, 
infusion of Ang IV into the cerebral spinal fluid facilitates memory retention and 
retrieval [Braszko et al.，1988]. Other functions of Ang IV include c-FOS activation in 
hippocampal pyramidal cells [Roberts et al., 1995], stimulation of plasminogen activator 
inhibitor-1 [Kerins et al.，1995] and inhibition of neurite outgrowth [Moeller et al., 
1996]. 
1.2.2 Tissue RAS 
There are increasing numbers of studies suggesting the existence of local 
angiotensin-generating systems, which operate in whole or in part, independent of the 
circulating RAS. The concept of the tissue RAS is based on the existence of a separate 
synthetic pathway in producing Ang II to meet the functional requirement of individual 
tissue. The close proximity of cells in tissue allows angiotensin produced locally to act 
in a paracrine or autocrine manner [Campbell, 1987; Dzau, 1984a]. In the paracrine 
manner，some cells produce Ang II and delivers it to the neighboring target effector 
cells，which bind and respond to the Ang II. The close proximity of the donor cells and 
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the effector cells facilitates the perseverance of Ang II and rapid response can occur 
between them. In the autocrine manner, Ang II produced and released from a cell acts 
back onto the same cell via its membrane receptors in order to exert its actions. Unlike 
the circulating RAS, which provides an extremely rapid and efficient homeostasis 
response to acute changes in blood pressure and fluid and electrolyte status, tissue RAS 
provides a more tonic and specifically local influence in those tissues where they exist. 
A number of discrete tissue RAS with local generation of Ang II was found to 
exist in a variety of organs such as the heart [Vecsei, 1978], brain [Okamura et al., 1981; 
Fishman et al., 1981], kidney [Morris and Johnson, 1976; Kawamura et al., 1985], 
adrenal [Aguilera et al , 1981; Okamura et al, 1984], testis [Pandey et al., 1984], arterial 
wall [Swales, 1979; Swales et al., 1983], epididymis [Leung et al., 2001a] and pancreas 
[Leung et al.，1999]. Expression of angiotensinogen mRNA and/or renin mRNA were 
detected in these tissues, providing strong evidence for their local synthesis in vivo. 
It is known from the available data that locally produced Ang II is generally 
concerned with the unique functions of each individual tissue in which it is formed 
[Ganong, 1995]. For example, Ang II and the cardiac RAS have been reported to be 
involved in cardiac growth and hypertrophy [Drexler et a l , 1989]; epididymal RAS has 
been revealed to have a regulatory role in mediating the epididymal and sperm functions 
[Leung, 2002]; and pancreatic RAS has also been shown to play a potential role in the 
fine regulation of pancreatic exocrine and endocrine functions such as regulating the 
pancreatic blood flow, functional ductal anion secretion and islet hormonal secretion. 
Some of these effects may be exerted via the markedly vasoconstrictor effects of RAS 
[Leung and Carlsson, 2001]. 
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1.3 Hypoxia and Carotid Body 
Hypoxia is the deficiency of oxygen reaching the tissues of the body. There are 
many potential causes of hypoxia and they can be classified into four general categories: 
(1) Hypoxic hypoxia, in which arterial oxygen alveolar gas pressure (PO2) is reduced; 
(2) Anemic hypoxia, in which arterial oxygen alveolar gas pressure (PO2) is normal 
while the total oxygen content of blood is reduced; (3) Ischemic hypoxia, where there is 
a significant reduction in blood flow or lack / loss of oxygen supply to tissue; (4) 
Histotoxic hypoxia, in which tissue cells are not capable to utilize the normal supply of 
oxygen because of some toxic agents or disorder of the cell itself. 
The response of the human carotid body to disease processes can be traced from 
the work of Arias-Stella in 1969. He reported that the carotid bodies of Quechua Indians 
living on the Andean Plateau were much larger than those of the Mestizos living on the 
costal region. The increase in size of the organ was due to the hypertrophy of the 
vasculature and the Type I cells [Arias-Stella, 1969]. Shortly after, the carotid bodies of 
animals living at high altitudes were shown to be larger than those of the same species 
living at the sea level [Edwards et al., 1971], whilst changes in Type I cell ultrastructure 
was found in guinea pigs that were bom and lived at an altitude of 4,300 m [Edwards et 
al, 1972]. It appeared that the most appealing aspect of the carotid body physiology for 
the clinician is the chronic response to hypoxia, which can be achieved by people living 
in high altitude or patients in chronic lung disease. 
Modeling of the human hypoxic states has been attempted in many mammalian 
species, the responses to chronic hypoxia seems to attain similar results including 
attenuated body growth or weight loss, right ventricular hypertrophy, pulmonary 
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vascular thickening of the media and extension of muscle into peripheral vessels with 
development of a new internal elastic lamina, polycythaemia and hypertrophy and 
hyperplasia of the carotid body [Bee and Howard, 1993]. 
Studies of the carotid body from animals in hypoxic conditions had been 
performed and the general aspect found is the organ enlargement due to a great increase 
in both the vasculature and the size of the Type I cells (Fig. 1-4). The volume increase 
in the rat carotid body is between three to six times; the change of vascularity is due to 
dilation，and there is proliferation of the endothelium [Barer et al.，1972; Dhillon et al., 
1984]. In chronic hypoxia, the surface area of blood vessels in the carotid body is 
increased some ten times. There is no change in the volume of Type I cells occupied by 
the nucleus, but there is hypertrophy of the cytoplasm. The total number of nuclei per 
carotid body is also increased some two- to four-fold. Counting from the nuclear 
numbers, the total Type I cell cytoplasm could be estimated as being increased some 
four times in chronic hypoxia [Dhillon et al., 1984]. The catecholamine levels in the 
chronically hypoxic animals were also been examined. It was found that chronic 
hypoxia causes a substantial increase in amine levels, such as noradrenaline and 
dopamine, in the rat carotid bodies, and the elevated levels return towards control levels 
on removal from the hypoxic environment [Fallot and Barer, 1982]. 
In addition, carotid body functions are also modulated by chronic hypoxia. For 
example, the carotid body releases catecholamines during hypoxia and this is believed to 
be an important step for the chemotransduction [Donnelly, 1993]. In chronic hypoxia, 
the production of catecholamines elevates in the carotid body and this is associates with 
an increase in the amount and activity of tyrosine hydroxylase, as demonstrated in rat 
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[Gonzalez et al.，1979; Hanbauer et al., 1981; Czyzyk-Krzeska et al, 1992] and in 
human [Lack et al , 1985]. Moreover, carotid afferent activities are known to play a role 
in the natriuresis and diuresis during chronic hypoxia, although the underlying 
mechanism is not clear [Honig, 1989]. 
Therefore it is obvious that the study of the hypoxic animals is valuable as it 
provides an animal model of human diseases resulting in chronic hypoxia, and 
information on the role of the carotid body under such conditions may be obtained. 
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1.4 Hypoxia and RAS 
The regulation of circulating RAS and tissue RAS is subject to a number of 
factors such as hormones, ions and stress [Philips et al., 1993]. Hypoxic stress is known 
to be one of such major factors that may lead to changes of RAS expression in a variety 
of tissues. Reports of the interference of hypoxia on various peripheral tissues RAS 
such as the kidney, the heart, the lung, the epididymis and the pancreas can be 
summarized as follows. 
In the kidney, hypoxia leads to a decrease in aldosterone secretion [Sutton et al.， 
1997]，thus disturbs water and electrolyte balance of the organisms leading to changes in 
urinary electrolytes [Janoski et al , 1991]. These influences are resulted from a complex 
interaction of the renin-angiotensin-aldosterone system. A number of reports showed 
that there is an increase in plasma renin activity after inspiratory hypoxia [Mattioli et al., 
1975; Milledge et al.，1983; Oparil et al., 1988]. Both renin secretion and renin gene 
expression are found to be stimulated by both acute hypoxic stress and venous hypoxia 
in vivo, but not in vitro [Ritthaler et al., 1997], suggesting an indirect stimulatory effect 
of hypoxia on the renin system, which may play a role in the sympathoadrenergic 
activation as there is an increase in plasma catecholamines levels [Somers et al, 1989; 
Mazzeo et al, 1991]. 
In the heart, hypoxia has a differential effect of ACE expression on right and left 
ventricle. Right ventricular ACE activity was increased by hypoxia while the ACE 
activity of the left ventricle was shown to have a decrease [Morrell et al.，1997]. 
Increased right ventricular ACE activity was positively correlated with right ventricular 
hypertrophy and this local increase of the ACE expression in the hypertrophied ventricle 
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would lead to an increase in the production of Ang II from its precursor, Ang I 
[Schunkertet al., 1990]. 
The pulmonary vasculature responds to chronic hypoxia by vasoconstriction and 
structural re-modeling [Riley, 1991]. It has been shown that the ACE activity of the 
whole lung is reduced by chronic hypoxia while the expression of Ang 11 receptors in 
lung membrane is increased [Kay et al.，1985; Jaderlinic et al., 1988]. Competition with 
specific Ang II antagonists showed that ATi is the predominant receptor subtype in both 
normal and hypoxic lung. It was suggested that Ang II, via the ATi receptor, has a role 
in the early pathogenesis of hypoxia-induced pulmonary hypertension in the rat [Morrell 
et al , 1995a; Zhao et al., 1996a]. 
It has also been shown that hypoxia has an inhibitory effect on the epididymal 
RAS [Leung et al., 2001a] but an excitatory effect on the pancreatic RAS [Chan et al., 
2000]. In the epididymis, hypoxic stress has been shown to reduce the transcriptional 
and posttranscriptional expression of angiotensinogen and thus affecting local generation 
of angiotensins. This down-regulation may be responsible for the decreased anion and 
fluid secretion by the epididymis and consequent disturbances in testicular function as 
observed in chronic hypoxia [Leung et al., 2001a]. However, in the pancreas, the 
activation of pancreatic RAS during chronic hypoxic stress is important for locally 
regulating pancreatic function such as blood flow and ductal anion secretion, and it may 
lead to hypoxia-induced pancreatic injury [Chan et al.，2000], such as pancreatitis 
[Leung et a l , 2000]. These data suggest that hypoxia has differential effects on both 
circulating RAS and tissue RAS and is intimately involved in both the physiology and 
pathophysiology of the respective tissues. 
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1.5 Hypoxia and RAS in Carotid Body 
It is shown from the previous sections that intimate relationships exist between 
hypoxia and the carotid body as well as the RAS. The significance of the interactive 
effects from which between hypoxia and the carotid body, or between hypoxia and the 
RAS are of no questions. Since both the carotid body and the RAS are shown to be 
somehow affected by hypoxia, linkages among the three seem to become a possibility 
and may even be present. 
In hypoxia, chemoreceptors in the carotid body increase the afferent activity of 
the carotid sinus nerve, which activates brainstem activities for the elevation of 
respiratory drive [Gonzalez et al , 1994]. The stimulation of carotid body 
chemoreceptors reflexly increases cardiac output, sympathetic flow and elevates 
circulating vasoactive hormones such as norepinephrine and Ang II for enhancing 
cardiovascular performance [Marshall, 1994]. 
Studies of hypoxia, the carotid body and the RAS indicate an important 
relationship among the three entitles. It was found that plasma Ang II level increases 
during hypoxia [Zakheim et al., 1976] and peripheral infusion of Ang II stimulates 
cardiorespiratory functions [Ohtake and Jennings, 1993]. The Type I cells of the carotid 
body are the receptor cells for peripheral chemoreception and their activity is associated 
with an increase in the intracellular calcium [Eyzaguirre and Abudara, 1995; 
Buckler, 1996; Vicario et al , 2000]. Interestingly, Ang II has also been demonstrated to 
increase the carotid body afferent activity, presumably via the mediation of the ATi 
receptor [Allen, 1998]. 
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1.6 Aims of Study 
Our hypothesis is that the neural response of the sinus nerve to Ang II might be 
mediated by the ATi receptor expressed in the Type I cell of the carotid body where 
[Ca2+]i may be increased via the activation of the AT! receptor. The activation of 
functional ATi receptors in Type I cells of the carotid body may in turn stimulate 
cardiorespiratory function and play role in the fluid and electrolyte homeostasis during 
stress of chronic hypoxia. Accordingly, the present study is aimed as follows: 
1.6.1 Existence of Functional Angiotensin II Receptors 
Given that Ang II modulates the afferent activity of the carotid body, there must 
be functional Ang II receptors exist in order to exert the effect. It is hypothesized that 
the neural response to Ang II is mediated by the ATi receptor expressed in the Type I 
cell of the carotid body. It is proposed that Ang II increases in the Type I cells 
via the activation of the ATi receptor. Thus, the first aim of the present study was to 
determine the [Ca2+]i response to Ang II in Type I cells dissociated from the rat carotid 
body using spectrofluorimetric measurement; to examine the transcriptional expression 
of ATi receptors in the carotid body using reverse-transcription polymerase chain 
reaction (RT-PCR); and to examine the localization of ATi receptors in the carotid body 
using immunohistochemistry. 
1.6.2 Regulation and Function of Angiotensin II Receptors by Chronic Hypoxia 
Provided that Ang II excites carotid body afferent activity, the carotid body 
response to Ang II may be modulated by chronic hypoxia and this could enhance the 
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afferent activity, which potentiate the cardiorespiratory response as well as the 
natriuretic and diuretic responses during chronic hypoxia. Accordingly, the second aim 
of the present study was to elaborate the regulation of chronic hypoxia on the expression 
and localization of Ang II receptors (ATu, ATib and AT2 subtypes), by RT-PCR and 
immunohistochemistry respectively; and to elucidate its effect on the chemoreceptor 
activity of the carotid body using in-vitro electrophysiology method. 
1.6.3 Existence of an Intrinsic Angiotensin-generating System 
In spite of the close association between the regulation and function of ATi 
receptor in the carotid body, there has been no evidence of the existence for an intrinsic 
RAS in the carotid body. Thus, the third aim of the present study was to demonstrate the 
existence of an intrinsic RAS in the rat carotid body. This was achieved by the study on 
the expression and localization of angiotensinogen, which is the mandatory component 
for a locally generated angiotensin system, in the carotid body at both gene level and 
protein level using RT-PCR, in-situ hybridization. Western blotting and 
immunohistochemistry methods. In addition, the study of the expression of renin and 
ACE were also performed by RT-PCR and Northern blotting in order to investigate the 
possible biosynthetic pathway of such local RAS system in the carotid body. 
1.6.4 Regulation of Local RAS by Chronic Hypoxia 
It has been shown that the expression of local RAS was regulated by hypoxia in a 
number of tissues and it may，in turn, lead to hypoxia-induced tissue injury. For 
example, the increased expression of Ang II receptors and ACE has been demonstrated 
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in chronically hypoxic rat lung and heart, indicating that activation of RAS by hypoxia 
should be important for the physiological and pathophysiological changes of these 
tissues functions. Accordingly, the fourth aim of the present study was to examine the 
expression changes and localization of angiotensinogen mRNA by RT-PCR and in-situ 
hybridization respectively; and to examine the expression changes of angiotensinogen 
protein by Western blot analysis. In addition, changes in the expression of ACE under 
hypoxic condition were examined using RT-PCR, while changes in activity of ACE 
were also investigated in a time course study using specific ACE activity assay. 
1.6.5 Studies of AT4 Receptor 
AT4 receptors are present in many tissues across several species and appear to 
have diverse functions. However，investigations of this relatively new receptor of RAS 
are still at their early age and are yet to be investigated. It is of interest to examine 
whether there is AT4 receptor present in rat carotid body. Thus, the final aim of the 
present study was to investigate the presence of AT4 receptors in rat carotid body using 
in-vitro autoradiography and fluorescence-conjugated Ang IV. 
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Chapter 2 Materials and Methods 
2.1 Experimental Animals and Rat Models 
Male adult Sprague-Dawley (SD) rats aged 28 days were used, unless where 
otherwise indicated. The animals were bred and raised under a pathogen free conditions, 
with a controlled ambient temperature of 20 土 广匸，relatively humidity of 60 to 80% and 
a 14 hour light / 10 hour dark cycle，in the Laboratory Animal Services Centre of the 
Chinese University of Hong Kong. Standard rat chow and tap water were supplied ad 
libitum. Ethical approval for the animal model and experimental procedures were 
obtained from the Animal Ethical Committee of the Chinese University of Hong Kong, 
Hong Kong. 
2.1.1 Rat Model of Chronic Hypoxia 
Experimental rats were exposed to an isobaric hypoxia chamber for a period of 4 
weeks. The hypoxic exposure was kept in moderate level (10% oxygen) relevant to the 
physiological and clinical conditions. It has been well documented that physiological 
adaptation developed during chronic hypoxia could lead to pathophysiological changes. 
Therefore, it is important that each chronically hypoxic treated animal model should be 
kept in maximal exposure of hypoxia over weeks until the physiological adaptation 
occurred. Compensation of the hypoxic stress in which development of full 
pathophysiological events that could influence the animal,s vitality would be attained. It 
is then possible to examine the physiological changes at both cellular and molecular 
levels for the adaptation or initial pathophysiological changes of the animal models. 
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Each set of 5 experimental rats were kept in an individual acrylic chamber filled 
with 10% 土 0.5% oxygen for isobaric hypoxia for 28 days; fresh water and sufficient 
chow were provided for the experimental animals everyday. The oxygen level was 
continuously monitored by an oxygen analyzer (Vacumetries, CA, USA) and was 
maintained by a servo-feedback control of solenoid valves that gated the inflow of pure 
nitrogen. The nitrogen was then allowed to mix with room air that was generated into 
the chamber by a pump at a speed of 1-2 liter/minute. Inside of each chamber, 
desiccator and soda lime were used to maintain the humidity and carbon dioxide 
condition. Each chamber was opened for approximately 15 minutes for regular 
maintenance every 2-3 days (Figure 2-1). 
To examine the time-course effect of hypoxic treatment on experimental rats, 
three other sets of animals at aged 28 days were conditioned in the above environment 
for 7 and 14 days respectively. Time and age matched rats kept in the same housing 
with normal room air supply were used as the normoxic controls. 
2.1.2 Isolation of Carotid Body 
Following deep anesthesia with halothane, adult SD rats were decapitated and 
the carotid body was dissected from the arterial bifurcation and the superior sympathetic 
ganglion in phosphate-buffered saline (PBS; 0.14 M NaCl, 2.7 mM KCl, 8 mM 
anhydrous Na2HP04,1.47 mM KH2PO4, pH 7.4). 
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Figure 2-1 The schematic diagram of the setup of hypoxic chamber. 
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2.2 Semi-quantitative Reverse Transcriptase-polymerase Chain Reaction (RT-
PCR) 
2.2.1 Total RNA Extraction and Quantification 
Carotid bodies of experimental treated rats were isolated as described in section 
2.1. Total RNA was extracted using Trizol reagent (Gibco-BRL, Life Technologies, 
Maryland, USA). For each reaction, 16-20 isolated carotid bodies were homogenized in 
2 ml Trizol reagent. Samples were incubated at room temperature for 5 minutes to allow 
complete dissociation of nucleoprotein complexes. Chloroform (0.4 ml) was added to 
each sample and vigorously shaken for 15 seconds. All samples were then incubated for 
3 additional minutes, followed by a centrifugation at 12,000 g for 15 minutes at 4�C. 
The upper colorless aqueous phase was carefully collected from each sample. RNA was 
precipitated out by addition of 0.1 ml isopropyl alcohol. After that, all samples were 
centrifijged at 12,000 g for 10 minutes at 4°C. The white pellets were collected and 
washed with 2 ml cold 75% ethanol, and were further centrifuged at 7,500 g for 5 
minutes. Finally, pellets were air dried, and dissolved in 0.1 ml diethyl pyrocarbonate 
(DEPC) (Acros, NJ, USA) treated water. 
Total RNA was quantified by spectrophotometer (UV-1601, Schimadzu, Kyoto, 
Japan). Total RNA concentration was calculated from the value of absorbance at 
wavelength 260nm (O.D. 260) x 40 x dilution factor and the purity of RNA obtained 
was determined by the ratio of O.D. 280 to O.D. 260. The calculated value lined in 
between 1.6 and 2.0 was considered as pure. 
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2.2.2 Reverse Transcription (RT) 
Total RNA (10 fig) was subjected to first-strand by Superscript Preamplification 
System (Gibco-BRL, Life Technologies, Maryland, USA). A 20|li1 reaction volume 
containing random hexamer, IX first strand buffer (250 mM Tris-HCl, pH 8.3; 375 mM 
KCl, 15 mM MgCy，1,4-dithiothreitol (DTT), deoxynucleotide (dNTP) mix and 
Superscript II transcriptase was incubated at 42®C for 50 minutes, the reaction was 
inactivated by heating at 70°C for 15 minutes. To remove RNA complementary to the 
cDNA，RNase H was added and incubated at 3TC for 20 minutes. 
2.2.3 Polymerase Chain Reaction (PCR) 
The resultant cDNA was subjected to PCR reaction. Various sets of 
oligonucleotide primers based on the corresponding RAS component genes were 
synthesized (Gibco-BRL, Life Technologies, Maryland, USA). Brief details of the RAS 
genes for the present study including the sequences of primers, expected PCR products 
and their references are shown in Table 2-1. 
PCR was carried out in a total of 20^1 reaction volume containing IX PCR 
buffer (20 mM Tris-HCl, pH 8.4; 50 mM KCl), 1.5 mM MgClz, 0.2 mM dNTP mix, 0.5 
|liM corresponding sense and anti-sense primers, template DNA and Tag DNA 
Polymerase (Gibco-BRL, Life Technologies, Maryland, USA). The reaction was 
initiated at 94°C for denaturing, then annealing at different temperature for different 
gene of interests and finally extending at 72°C. The cycle was repeated for 25-35 cycles. 
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Figure 2-2 The schematic diagram showing the general principle of RT-PCR. 
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2.2.4 Gel Electrophoresis 
The PGR products were analyzed on an agarose gel (2% agarose wt/vol in IX 
TAB buffer，0.04 M Tris-acetate, 0.01 M EDTA) pre-stained with 40)LI1 of Img/ml 
ethidium bromide (Gibco-BRL, Life Technologies, Maryland, USA). The resulting 
bands were visualized using a camera equipped with an UV illuminator (FluroChem 
8000 Advanced Fluorescence, Chemiluminescence and Visible Light Imaging, Alpha 
Innotech Corporation, CA, USA). 
2.2.5 Optimization of Semi-quantitative RT-PCR for RAS Gene Analysis 
For the interpretation of semi-quantitative RT-PCR data to be meaningful, PGR 
reaction should be terminated when the products from genes of interest are detectable 
and are amplified within linear range. The linear range of amplification occurs in the 
PCR cycles when reaction components are still in excess and the PGR products are 
accumulating at a constant rate. Two sets of experiments were conducted on each gene 
for validation of PCR amplification in the logarithmic phase. Different amounts of 
cDNA mixture were amplified for 27 cycles of PCR using primers for the RAS 
components and p-actin. cDNA mixtures with concentration laying in the linear range 
were subjected to PCR amplification in a 20 reaction system for 25-35 cycles. 
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2.3 Northern Blotting 
RNA samples from carotid bodies were extracted with Trizol reagent (Section 
2.2.1), and were separated by running on a 1.2% formaldehyde gel electrophoresis (2.7 
ml lOX MOPS (3-(N-morpholono)propanesulfonic acid)，4.3 ml formaldehyde, 0.65 g 
agarose, 40 pd of Img/ml ethidium bromide，all dissolved in 44.3 ml DEPC treated 
water). The result was photographed using an UV illuminator. 
2.3.1 Transfer of Denatured RNA to Nitrocellulose Membrane by Capillary 
Elution 
The gel was brought to a cleaned-glass baking dish. The unused area of the gel 
was trimmed away with a razor blade. The bottom of left-hand comer of the gel was cut 
off to serve as the orient of gel during the transfer. A piece of Whatman 3MM filter 
paper was placed on a piece ofPiexglas to form a support that was longer and wider than 
the gel. The glass support was then placed inside the baking dish. The dish was filled 
with 20X SSC (175.3 g NaCl and 88.2 g Sodium Citrate dissolved in DEPC-treated 
water，pH 7.0 with NaOH, volume was made up to 1 L and then autoclaved) until the 
level of the liquid reached 5 mm below the glass support. All air bubbles were smooth 
out with a glass rod when the 3MM paper on the top of the support was thoroughly wet. 
A fresh scalpel was used to cut a piece of nitrocellulose membrane (Hybond H+ 
Nylon Membrane; Amersham Biosciences, NJ, USA) about 1 mm bigger than the gel in 
both dimensions. The filter was handled with blunt-ended forceps and was pre-wetted 
with 20X saline sodium citrate (SSC) for 5-10 minutes before applied in the transfer 
procedures. 
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For the transfer processes, the gel was placed on the support in an inverted 
position so that it was centered on the wet 3MM paper. The pre-wetted nitrocellulose 
membrane, followed by a small stack of 3MM paper (dimensions about the same as the 
gel), followed by a larger stack of paper towel (about 3-6 cm in height), and finally a 
500-800 g weight were all placed on top of the gel. The transfer of RNA from gel to the 
nitrocellulose filter took approximately 10-18 hours (Fig. 2-3). 
The nitrocellulose membrane was rinsed and soaked in 6X SSC for 10 minutes 
after the transfer procedures. The filter was then allowed to dry briefly in room air until 
no dripping occurred. Finally, the filter was subjected to UV cross-linking (1200 ^J for 
90 seconds, Stratalinker; Stratagene Inc., CA, USA) to fix all RNA samples on the 
membrane for further usage. 
2.3.2 Hybridization 
The 32p_labelled probes from full-length cDNA of rat renin [Bumham et al., 
1987] were generated by digesting the pBluescript plasmid containing 1434 bp renin 
sequence. The digested fragment was radioactively labeled using the Ready-to-go DNA 
labeling kit (Pharmacia Biotech, NJ, USA). Hybridization was performed with 100 ng 
of ^^P-labelled probes (0.7 X 10^ dpm/^g) in Rapid-hyb buffer (Amersham Biosciences, 
NJ, USA) at 65X overnight. The blots were washed in 2X SSC, 0.1% SDS at room 
temperature for 20 minutes X 2, followed by O.IX SSC, 0.1% SDS at 65V for 15 
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Figure 2-3 Diagrammatic representation of a capillary blotting apparatus. 
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2.4 In-situ Hybridization 
A 596 bp PCR product from rat Angiotensinogen mRNA [Ohkubo et al.，1983] 
was cloned into the Smal site of plasmid Bluescript KS (Promega, WI, USA). This 
Angiotensinogen cDNA was used to generate digoxigenin-labelled sense and antisense 
riboprobes using T3 and T7 polymerase respectively according to the manufacture's 
instruction (Boehringer Mannheim, Mannheim, Germany). 
2.4.1 Linearization of Angiotensinogen cDNA 
A 50 |Lil reaction mixture with appropriate amount of Angiotensinogen cDNA, 5 
jLil H buffer and 1 i^l Xbal (10 U/|LI1) (for antisense probe) / EcoRI (10 U/|LI1) (for sense 
probe) in DEPC water was incubated at 37°C for 1 hour. After the incubation, the 
reaction mixtures were extracted with phenol/chloroform/isoamyl alcohol (2.5/2.5/1) 
and centrifuged at 9,000 rpm for 15 minutes. The supematants were again extracted 
with 50 |il chloroform and centrifuged at 9,000 rpm for 15 minutes. To the supernatant 
was added 3M NaOAC (10% volume of the supernatant kept) and 100 i^l - 2 0 � �e t h a n o l 
and kept at -70®C for 30 minutes. The supernatant was centrifuged at 13,500 rpm at 4°C 
for 15 minutes. After rinsing with 70% alcohol, the pellets in each tube were dried and 
dissolved in 20 TE buffer. 
2.4.2 Riboprobe Preparation 
A 20 |Lil reaction mixture with 1 |Lig linearized DNA, 2 |il lOX DIG RNA labeling 
mix (Roche, Mannheim, Germany), 2 |LI1 lOX transcription buffer, 1 RNase inhibitor 
(40 U/ml) and 2 T3/T7 polymerase (20 U/ml) in DEPC water was incubated at 3TC 
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for 2.5 hours. The reaction mixtures were incubated with 2 Units DNase (10 U/|LI1) at 
37�C for 15 minutes. Followed by addition of 2 |iil EDTA (200 mM EDTA at pH 8.0)， 
28 |Lil TE buffer, 3 jil LiCl (7.5 M; 3 parts lOM LiCl and 1 part DEPC-treated water) and 
100 |xl cold ethanol, the reaction mixture was left at -70°C for 30 minutes. The reaction 
mixtures were centrifuged at 13,500 rpm at 4®C for 15 minutes. The resultant pellets 
were collected, rinsed with adequate amount of 70% ethanol, and followed by another 
centrifugation at 9,000 rpm at 4°C for 5 minutes. The pellets were collected and allowed 
to dry at room air and were re-suspended in 15 |li1 DEPC-treated water. All the 
chemicals used were supplied by Boehringer Mannheim, Mannheim, Germany unless 
otherwise indicated. 
2.4.3 Quantification and Gel Electrophoresis of Riboprobes 
To confirm the identity of the prepared riboprobes, the riboprobes were 
quantified by spectrophotometer (Section 2.2.1) and separated by running on a 1.2% 
formaldehyde gel electrophoresis (Section 2.3). The result was photographed using an 
UV illuminator and the expected products size for both the sense and anti-sense 
angiotensinogen riboprobes should be 600 bp. 
2.4.4 In-situ Hybridization Histochemistry 
Immediately after carotid bodies from the SD rats were dissected out, they were 
frozen in embedding medium using isopentane. Cryosections (10 |im) were cut on a 
Cryotome (Shandon AS 620，Cryotome, Cheshire, UK) and dried immediately at 50°C 
for 2 minutes before fixing with freshly prepared 4% (wt/vol) paraformaldehyde at 4°C 
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for 1 hour. Sections were first digested with 1 |ig/ml of proteinase K for 15 minutes, 
rinsed in 0.1 M triethanolamine and acetylated in 0.25% (vol/vol) acetic anhydride for 
20 minutes at room temperature. Prehybridization was preformed by incubating sections 
with 50% (vol/vol) formamide, containing 4X SSC for 30 minutes at 42°C. 
Hybridization was performed overnight at 42°C in a humidified chamber with antisense 
or sense riboprobe (20 ng/jiil) containing 50% (vol/vol) formamide, 4X SCC, 0.25 mg/ml 
yeast tRNA (Gibco-BRL, Life Technologies, Maryland, USA), 0.25 mg/ml salmon 
DNA (Gibco-BRL, Life Technologies, Maryland, USA), 100 mg/ml dextran sulfate 
(Sigma, MO, USA) and IX Denhardt's solution (Sigma, MO, USA). Post-hybridized 
sections were then washed with 2X SCC containing 50% (vol/vol) formamide at 50�C. 
Excess probe was removed by digestion with RNase A (40 ^ig/ml) (Roche, Mannheim， 
Germany) for 30 minutes at 37�C. Sections were finally washed sequentially with 2x 
SCC, IX SCC, followed with 0.5X SCC at 37T. Hybridized probes were detected with 
anti-digoxigenin antibody conjugated to alkaline phosphatase (1:500) (Boehringer 
Mannheim, Mannheim, Germany) and visualized by NBT/BCIP detection (Boehringer 
Mannheim, Mannheim, Germany). The sections were mounted directly in aqueous 
mounting medium (Clearaiount Zymed Laboratories, CA, USA). The resultant sections 
were then photographed under a light microscope equipped with a DC-200 camera 
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Figure 2-4 Summary of in-situ hybridization protocol for detection of RNA. 
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2.5 Immunohistochemistry 
2.5.1 Preparation of Cryosection 
Carotid bifurcations from SD rats (n = 8) were removed and rinsed in PBS. 
Tissues were embedded in an OCT compound (Tissue-Tek, Sakura, Tokyo, Japan), 
which was used to create a more uniform block to facilitate sectioning. Embedded 
tissues were immediately frozen in a frozen isopentane, which was pre-cooled in liquid 
nitrogen. Cyrosections (8 |Lim) were cut on a cryotome and were incubated with 20% 
sucrose at 4°C overnight. Sections were stored at -70®C until use. 
2.5.2 Indirect Immunoperoxidase Staining 
Sections were air-dried at room temperature for 30 minutes and fixed with 4% of 
4°C PFA for 8-10 minutes. After sufficient washing in phosphate-buffered saline (PBS, 
pH 7.4)，sections were rinsed in methanol containing 0.3% H2O2 for 30 minutes to 
remove endogenous peroxidase activity. Sections were washed again and incubated 
with diluted normal blocking serum for 30 minutes at room temperature. The serum was 
prepared from the species in which the secondary antibody is made. Excess blocking 
solution was removed and the primary antiserum was applied for 1 hour or overnight at 
4°C. The sections were washed with PBS and then incubated with diluted biotinylated 
secondary antibody for 1 hour at room temperature. After washing the sections for 
several times, they were incubated for 1 hour with ABC reagent (Vectastain Elite ABC 
Kit, Vector Laboratories, CA, USA) (Fig. 2-5A). Positive immunoreactivity was 
visualized by reacting the sections with Vector VIP substrate kit (Vector Laboratories, 
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CA, USA). Sections were then counterstained with haematoxylin, dehydrated, cleared, 
mounted and examined under light microscopy. 
2.5.3 Immunofluorescent Double Staining 
All sections were fixed with 50% acetone/methanol (vol/vol) at -20°C for 30 
minutes; they were then processed for indirect immunofluorescent double staining (Fig. 
2-5B). Each section was incubated overnight at 4�C with anti-rat angiotensinogen serum 
[Thomas and Sernia, 1988]，diluted to 1:200 and with anti-tyrosine hydroxylase serum 
(Chemicon International Inc., CA, USA), diluted to 1:500 overnight at 4°C. After 
several washes with PBS, the primary antibodies were detected using anti-rabbit labeled 
with Rhodamine for angiotensinogen and anti-sheep labeled with 
Aminomethylcoumarin Acetate (AMCA) for tyrosine hydroxylase (Chemicon 
International Inc., CA, USA) at room temperature for 2 hours. Positive 
immunoreactivity for angiotensinogen (red) and for tyrosine hydroxylase (blue) was 
examined with a fluorescent microscope equipped with a DC 200 digital camera (Leica 
Microsystems Ltd., Heerbrugg, Switzerland). The following controls were used: (1) 
substitution of primary antibodies with buffer; (2) incubation with rabbit non-immune 
serum; (3) liquid phase preadsorption of angiotensinogen with excess blocking peptide 
(Santa Cruz Biotech Inc.，CA，USA). 
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Figure 2-5 A. The basic principle of ABC staining. 
B. The schematic diagram of immimofluorescent double staining. 
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2.6 Western Blot Analysis 
2.6.1 Preparation of Angiotensinogen Protein 
Rat carotid bodies were homogenized at 4°C in solution (1:9 wt/vol) containing 
10 mM ethylenediaminetetraaectic (EDTA), 1 mM phenylmethylsulfonyl fluoride 
(PMSF). The homogenate was centrifuged at 10,000 g at 4°C for 60 minutes, and the 
pH was adjusted to 4.5 by adding adequate amount of acetic acid. The reaction mixture 
was further centrifuged at 1,000 g for a brief time to allow resultant supernatant 
collection. The concentration of protein was determined before subjected to sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). 
2.6.2 Quantification of Protein Concentration 
Bio-Rad Protein Assay (Bio-Rad, CA, USA) was used in protein quantification. 
The protocol involved the addition of an acidic dye to protein solution, and followed by 
measurement at 595 nm with a spectrometer (UV-1601, Shimadzu, Kyoto, Japan). 
Relative measurement of protein concentration was interpolated with the standard curve. 
Dye reagent concentrate was diluted with distilled water in 1 to 4 X dilution. 
Equal amount of diluted dye solution was added to different concentration (0.2 to 0.8 
mg/ml with 0.2 X increment) of bovine serum albumin (BSA) that was used as the 
standard, and protein samples respectively. All samples were incubated at room 
temperature for 5 minutes and absorbance at 595 nm were measured. 
2.6.3 Sample Preparation 
45 
One part of protein sample was mixed with two parts of laemmli sample buffer 
(Bio-Rad, CA, USA) (62.5 mM Tris-HCl, pH 6.8; 25% glycerol; 2% SDS and 0.01% 
Bromophenol Blue) containing 5% p-mecaptoethanol. It was heat denatured at 100°C 
for 5 minutes. 
2.6.4 Sodium Dodecyl-sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
The protocol for SDS-PAGE was based on Laemmli's report [Laemmli, 1970]. 
Polyacrylamide gel electrophoresis is an imperative procedure in protein 
characterization. The analysis of structure and composition of the target protein are 
carried out after the separation of a complex mixture of macromolecules by PAGE. 
The type of electrophoresis carried out in this part of experiment is called 
discontinuous electrophoresis in which two layers of gel were cast in the same slab gel 
apparatus. The upper layer called staking gel contained 4% acrylamide allowing protein 
samples to be concentrated into staked bands before entering the lower layer, separating 
gel with 12% acrylamide. Apart from the difference in acrylamide concentration, they 
also contain 10% SDS which is an anionic detergent, polymerizing agent ammomium 
persulfate (APS) and addition of N,N,N,-N'-tetramethylene-diamine (TEMED) for 
accelerating the polymerization. Heat denatured protein samples were added to the gel 
for electrophoresis (Mini-PROTEAN II system, Bio-Rad, CA, USA) at 120 volts for 1.5 
hours. 
2.6.5 Electroblotting and Immunodetection of Proteins 
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The gel was equilibrated in electroblotting buffer (48 mM Tris/ 39 mM glycerine 
containing 20% methanol) for 30 minutes after the completion of gel electrophoresis. 
Protein was immobilized on a polyvinylidene difluoride (PVDF) membrane (Micron, 
MA, USA). According to manufacturer's instruction, membranes were firstly immersed 
in methanol for approximately 10 seconds, equilibrated in electroblotting buffer for 30 
minutes. Electroblotting was conducted by Semi-Dry Transfer System (Bio-Rad, CA, 
USA) at 15 volts for 30 minutes. 
Membranes were blocked in blocking solution (5% non-fat skimmed milk); the 
blotted PVDF membrane was saturated with 5% (wt/vol) of skimmed milk in PBS, pH 
7.4 and 0.1% (vol/vol) of Tween 20 for 1 hour at room temperature. The membrane was 
sequentially incubated in rabbit anti-rat angiotensinogen serum [Thomas and Semia, 
1988], diluted to 1:2500 overnight at 4°C and a peroxidase-labelled anti-rabbit IgG 
(Boehringer Mannheim, Mannheim, Germany), diluted to 1:200 for 2 hours at room 
temperature. After thorough washing, the positive band was revealed using ECL 
detection system (Amersham Biosciences, NJ, USA) (Fig 2-6). 
Separation of protein sample by SDS-PAGE 
� y ‘ 
Transfer to PVDF membrane Block the non-specific sites 
f —— 
Incubation with primary antibody Incubation with HRP-labeled 
乂 y conjugated antibody 
ECL detection 
乂 / Exposure to film 
Figure 2-6 Summary of Western blotting analysis protocol. 
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2.7 Spectrofluorimetric Measurement and In-Vitro Electrophysiology 
2.7.1 Dissociation of Carotid Body Type I Cells and Spectrofluorimetric 
Measurement 
Following enzymatic treatment, the carotid body cells were dispersed by gently 
triturating with glass pipettes [Donnelly and Khlowadwala, 1992]. Cells in 1 mL 4-(2-
hydroxyethyl)-1 -piperazineethanesulphonic acid (HEPES)-Ringer (140 mM NaCl, 3 
mM KCl, 1.25 mM NaHzPOq，1 mM MgClz, 1 mM CaCl!, 10 mM HEPES, 25 mM D-
dextrose at pH7.4) were incubated in 5 ]uM fura-2 acetoxymethyl ester (fura-2AM, 
Molecular Probes, Eugene, Ore., USA) for 30 minutes in the dark at room temperature. 
The cells were then centrifiiged at 200 g for 5 minutes and prepared for the 
spectrofluorimetric measurement of [Ca^^Ji [Biscoe et al., 1989; Wasicko et al., 1999]. 
Type I cells in clusters of 8-20 cells were studied and the morphological criteria for their 
confirmation as type I cells was done. 
[Ca2+]i was measured in fura-2-loaded Type I cells freshly dissociated from rat 
carotid bodies. The cells were seeded on a cover-slip placed on the stage of an inverted 
microscope equipped with a dual-wavelength excitation spectrofluorimeter. The cells 
were perfiised with HEPES buffer at 0.5 ml/min at room temperature. Background 
fluorescence intensity was substracted from the signals. Fluorescent signals were 
obtained at 340 and 380 nm excitation wavelengths (Fig. 2-7). The ratio of the 
fluorescence intensity (340/380) was used to estimate in the Type I cells. The 
[Ca2+]i was calculated by using the equation: [Ca^^], = K^ [(Ro-Rnun)/(Rmax-Ro)]P where 
Ro is the fluorescence ratio; Rmm is the fluorescence ratio at zero Ca^^; R^ax is the 
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fluorescence ratio at saturated Ca^^; K<i is the dissociation constant for fura-2 (224 nM) 
and p is the ratio of fluorescence intensity (380 nm) at zero Ca^^ to fluorescence 
intensity (380 nm) at saturated Ca^ .^ 
Concentration dependence was determined by the response to Ang II 
(Sigma，MO, USA) at 10，50 and 100 nM. Ang II was injected as a bolus into the 0.5 ml 
bath. The antagonist for AT】，losartan (1 |LIM) (Sigma, MO, USA), or for AT2, 
PD123319 (1 ]M) (Sigma, MO., USA), was perfused for 3 minutes before Ang II 
treatment. At the end of the experiment, acute hypoxia was induced by NaCN (2 mM, in 
bolus) (Sigma, MO, USA) to confirm the chemosensitivity of the Type I cells. 
2.7.2 In-vitro Electrophysiology 
The isolated carotid body was incubated in collagenase and protease for 30 
minutes at 35�C [Donnelly and Khlowadwala, 1992]. It was then held in the recording 
chamber at 35 土 lOQ and perfused (2-3 ml/min) with oxygenated Ringer (125 mM 
NaCl, 3.1 mM KCl, 1.25 mM NaHzPO*’ 1.3 mM MgClz, 2.4 mM CaClz, 10 mM D_ 
dextrose at pH7.4) and the sinus nerve was recorded for single- or pauci-fiber activities 
with suction electrodes. The signal was amplified, filtered, monitored, digitized and 
storage for analysis (Fig. 2-7). Ang II (0.1-100 mM) was perfused for 3 minutes for the 
dose-dependent response. For the blockage of the ATi receptor, losartan (1 ^M), was 
perfused for 10 minutes before the Ang II (100 nM) treatment. Acute hypoxia was 
induced by perfusion of rat Ringer gassed with (95% N2 and 5% CO2) to confirm the 
chemosensitive of the afferent fibers. 
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Figure 2-7 The schematic diagram of spectrofluorimetric measurement and in-vitro 
electrophysiology. 
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2.8 Assay of ACE Activity 
2.8.1 Crude Membrane Preparation 
Tissues were homogenized in 1:9 (wt/vol) PBS (pH 7.4) containing 1 mM PMSF. 
The homogenate was sediment at 1,000 g for 10 minutes at 4°C. Discarded the pellet 
and spin the membrane fraction within the supernatant portion at 30,000 g for 30 
minutes at 4°C. Suspended the resultant pellet with PBS (pH 7.4) containing 1 mM 
PMSF and measured the protein concentration by the Bio-Rad protein assay (Section 
2.6.2). 
2.8.2 Basic Principle for ACE Activity Measurement 
The principle for the measurement of the ACE activity was mainly based on a 
fluorogenic substrate specific for ACE. It is a four amino acid long peptides with 
structure as Methoxycarbonyl-Amp-Gly-Lys(DNP) and acts as the quencher of 
fluorescence. By the action of ACE on the fluorogenic substrate, the bond between 
Glycine and Lysine(DNP) was cleaved such that the fluorescent product was released 
from the quencher of DNP (Fig. 2-8). The amount of this fluorescent product was 
measured by fluorimeter. 
2.8.3 Measurement of ACE Activity 
Membrane proteins (5 |Lig) were pre-incubated with Tris buffer (100 mM Tris 
HCl, pH 8.0 and 300 mM NaCl) in a final volume of 950 i^l at 37°C for 30 minutes. For 
the control set, 15 mM captopril (Sigma, MO.，USA) was added to inhibit the ACE act-
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Methoxycarbonyl 一 Amp 一 Gly __ Lys(DNP) 一 Gin 一 OH 
• 
Methoxycarbonyl Amp Gly 
Fluorescent Product 
Amp: A fluorescent amino acid 
DNP: A quencher of fluorescence 
Figure 2-8 The schematic diagram of the basic principle for ACE activity 
measurement. The structure of a fluorogenic substrate for ACE was 
shown in which the Amp was a fluorescent amino acid. The fluorescence 
of Amp was quenched by DNP, which was a quencher of fluorescence in 
the absence of ACE. By the action of ACE, the bond between glycine 
and lysine(DNP) was broken such that the fluorescent product released 
from its quencher of fluorescence. 
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-ivity. In the presence of captopril, the fluorescence reading of the controls should be 
close to that of the blank. 
After pre-incubation, 50 |LI1 of 0.4 mM fluorogenic ACE substrate (0.32 mg/ml in 
Tris buffer) was added to the mixtures and was incubated again at 37®C for 60 minutes. 
The fluorescence of the mixtures was measured by a fluorimeter (F-4010 Fluorescence 
Spectrophotometer; Hitachi, Japan). 
2.8.4 Fluorescence Measurement 
Mixture of 50 |il ACE substrate and 950 |nl Tris buffer was used as the blank and 
was used to set zero with excitation at 328 nm and emission at 392 nm of the fluorimeter. 
Fluorescent standard of 0.1 mM (37.8 mg/L in Tris buffer) was diluted to give 1 ^iM 
solution as a reference reading for calculating the ACE activity in fxmol/|xg/min of 
protein (Fig. 2-9). 
^ [ ^ ^ M e m b protein preparation^^^^^ 
f Pre-incubate 
\ with Tris buffer ^ ^ ^ 
<Controls ^ . Z Samples 
Addition of ^ J 1 (Captopril ) \ 1 
^[[^I^^Addition of ACE substrate ^ ^ ^ 
iXQ Fluorescence measurement ^^^ ？^ 
Figure 2-9 Summary of the assay of ACE activity. 
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2.9 In-vitro Autoradiography and Fluorescence-labeled Binding Assay for 
Angiotensin IV 
To determine the localization and density of the AT4 receptor in frozen tissue 
sections using a radioactive ligand, ^^ I^-Ang IV (PerkinElmer, Boston, USA) and a 
fluorescence-labeled ligand, Fluorescein Isothiocyanate (FITC)-Ang IV (Auspep, 
Victoria, Australia). 
2.9.1 Preparation of Frozen Tissue Sections 
See Section 2.5.1 for detailed except cryosections of 10 |im were used. 
2.9.2 Localization and Density of AT4 Receptor 
All frozen slide sections were firstly thawed to room temperature. Slides were 
then washed with PBS, pH 7.4, at room temperature for 10 minutes. To maintain tissue 
sections' morphology, slides were fixed with 2% paraformaldehyde (PFA) for 10 
minutes at room temperature, followed by washing in PBS for 10 minutes at room 
temperature. Slides were then allowed to dry in a stream of air. After drying, a 
chirography pen was used to draw a hydrophobic barrier around the section of 
approximately the same size as the tissue to provide an incubating well. 
Tissue-sections were equally divided into three groups (n=3/group) for various 
treatments as shown in Table 2-2. The Ang IV incubation buffer contained 59.3 jul of 50 
}xM Plummers Inhibitor (DL-2-2-Mercaptomethyl-3-guanidinoetyhiopropanoic acid) 
(Calbiochem, CA，USA), 17.2 of 11 fiM Bestatin (Sigma, MO，USA) and 30 mg of 
0.6% BSA in 5 mL PBS (Table 2-3). Non-specific bindings of the labeled Ang IV 
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ligand on tissue sections were verified by addition of 10"^  M non-labeled Ang IV 
(Angiotensin II (3-8); Auspep，Australia); whereas M Sarile ([Sar^ Ile^]-
Angiotensin II; Sar-Arg-Val-Tyr-Ile-His-Pro-Ile) (Sigma，MO.，USA) was used to 
demonstrate the specificity of the labeled Ang IV ligands (Table 2-3). All treated slides 
were allowed to incubate for 30 minutes at room temperature. 
After incubation, slides were washed twice in PBS for 1 minute at 4°C, followed 
by washing in double distilled water (d^H20) for 30 seconds at 4°C. Slides were then 
allowed to dry in a fumehood overnight. Resultant signals for FITC-Ang IV ligands on 
tissue sections were examined with a fluorescent microscope equipped with a DC 200 
digital camera (Leica Microsystems Ltd., Heerbrugg, Switzerland); and that for ^^^I-Ang 
IV ligands were examined by exposing slides in Kodak Biomax film at -20°C for 3 days 
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2.10 Statistics and Data Analysis 
For the [Ca2+]i，the resting and peak values of the fluorescence ratio of (340/380 
nm) or calibrated [Ca2+]i (in nanomole/litre) of the responses during drug treatment were 
calculated. Values were normalized as a % of control if necessary and presented as 
mean 土 SE. Means were compared with the paired 卜test or the non-parametric 
Wilcoxon signed-rank test for pre- and post-treatment. ANOVA with tukey test was 
used for multiple comparisons of values in drugs studies among groups with different 
concentrations. Differences were considered significant at p<0.05. 
For In-vitro electrophysiology, the discharge rate (spike/second, average over 1-3 
minutes) was compared before, during and after the drug treatment. Values were 
normalized in % control of resting activity and were presented as mean 土 SE. Statistical 
comparisons between the response to Ang II in normoxic and chronically hypoxic group 
were made by ANOVA with tukey test. The same analysis was used for comparison in 
drugs studies among groups. Differences were considered significant at P<0.05, 
All gel images from RT-PCR and Western blot analysis were analyzed and 
quantified by an UV illuminator (FluroChem 8000 Advanced Fluorescence, 
Chemiluminescence and Visible Light Imaging, Alpha Iimotech Corporation, CA, USA). 
The RAS component genes expression is normalized in % control of the P-actin 
expression for the RT-PCR. Results were expressed as the mean 土 SE. Statistical 
comparisons and differences between mean values of normoxic and hypoxic group were 
compared using unpaired Student's t-test. Significant differences were determined when 
P<0.05. 
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Chapter 3 Results 
3.1 Functional Expression of Angiotensin II Receptors 
As the very first step to demonstrate our hypothesized relation between RAS and 
the carotid body, the expression and function of Ang II receptors were investigated in rat 
carotid body. 
3.1.1 [Ca2+]i Response to Angiotensin II 
Ang II (10-100 nM) increased in all of the responsive (33 out of 85 
clusters, i.e. 38.8%) clusters of Type I cells. The peak response was reached shortly 
after Ang II stimulation and gradually returned to the resting level within 3 
minutes (Fig. 3-1 A). The increase in [Ca2+]i in response to Ang 11 (100 nM) was 30.5 土 
4.9 nM (n=24) on average. Besides, different concentrations of Ang II (10，50,100 nM) 
were tested in 12 clusters of type I cells. The increase in response to Ang II was 
concentration dependent (Fig. 3-1 A, B). 
3.1.2 Antagonistic Blockade of Angiotensin II Receptor Subtypes 
Losartan treatment (1 i^M) per se did not change the resting but it largely 
abolished the response to Ang 11 in the type I cells (P=0.1, paired Mest, n=6) (Fig 
3-2A). There were a significant difference in the Ang H-induced peak changes in 
pre- and post- treatment of losartan (P=0.03, paired Mest, n=6) (Fig. 3-2C). In contrast, 
PD123319 did not cause any significant difference in the peak response to Ang II 
(P=0.02, n=6) (Fig. 3-2C), nor did the treatment per se change the [Csl^^I (P=0.5, pair t-
test, n=6) (Fig. 3-2B). 
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Figure 3-1 A. Both Ang I I (10-100 nM) and histotoxic hypoxia wi th cyanide (NaCN， 2 mM) increased the of the dissociated type I cells of carotid bodies. B. Concentration/response relationship for Ang Il-induced 
increases in type I carotid body cells (n=120). •P<0.05 vs. 10 nM Ang 
II. 
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Figure 3-2 Blockade of ATi but not AT2 receptor subtypes attenuates the Ang II-
induced change. A. Effect of the ATi antagonist losartan 
(perfusion for 3 minutes, bar) on response to Ang II (100 nM, 
arrows). B. Lack of effect of the AT! antagonist PD123319 (perfusion for 
3 minutes, bar) on the response to Ang II (100 nM, arrows) in a 
cluster of carotid body type I cells. C. Summary of effects of losartan 
and PD123319 on the Ang II following the drug treatment is normalized 
to that of the pretreatment (% Control); mean 土 S.E.M. •P<0.05 vs. 
corresponding pretreatment group. 
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3.1.3 Expression of ATi Receptors mRNA 
To determine the mRNA expression of ATi receptors in the rat carotid body, the 
gene transcripts of ATi subtypes, ATia and ATib, were detected by RT-PCR using specific 
oligonucleotide primers based on the corresponding genes. The RT-PCR products of 
ATla (385 bp) and ATib (204 bp) were found in carotid bodies (Fig. 3-3), indicating the 
mRNA expression of ATi receptors. As a positive control, the expression of ATia and 
ATlb was shown in the adrenal gland. The internal control for the RT-PCR study was the 
P-actin expression (240 bp) in the carotid bodies. 
3.1.4 Cellular Localization of ATi Receptors Protein 
To determine the localization of ATi receptors in the rat carotid body, ATi 
immunoreactivity was detected by using a receptor-specific antibody. Faint-to-moderate 
positive immimostaining was observed in the carotid body parenchyma (Fig 3-4A). The 
staining was scattered in lobules of type I cells (Fig. 3-4B). Neither preabsorption of the 
antibody nor replacement of the antibody with buffer yielded positive immimostaining in 
the carotid body sections at low magnification (Fig 3-4C) and high magnification (Fig. 
3-4D). 
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Figure 3-3 RT-PCR analysis of ATi receptor mRNA in rat carotid body. Lane M, 
DNA marker; Lane 1, ATia expression in carotid bodies; Lane 2，ATib 
expression in carotid bodies; Lane 3, p-actin expression in carotid bodies; 
Lane 4, ATia expression in adrenal gland; Lane 5, ATib expression in 
adrenal gland. The expected size of PCR products from ATi receptors is 
385 bp for ATia subtype and 204 bp for ATib subtype and that from p-
actin is 240 bp. 
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Figure 3-4 ATi -immunoreactivity in the rat carotid body. A. Low magnification 
(20x) showing the faint-to-moderate immunostaining in the carotid body 
parenchyma. B. High magnification (40x) showing localization of 
staining scattered in lobules of the carotid body. C & D. Consecutive 
sections of the carotid body treated by preadsorption of the primary 
antibody and counterstained with haematoxylin at low (C) and high (D) 
magnification. Scale bars are 40 i^m at low and 80 |xm at high 
magnification. 
63 
3.2 Effect of Chronic Hypoxia on the Expression and Function of Angiotensin II 
Receptors 
As evidenced by the previous section that Type I cells in rat carotid body express 
functional Ang II receptors in which the binding of Ang 11 to the ATi receptors lead to an 
increase in a key step of the intracellular signaling cascade, following the 
activation of the receptors. The effects of chronic hypoxia on the expression and 
localization of Ang II receptors and its effect on the chemoreceptor activity of the carotid 
body were to be investigated next. 
3.2.1 Effect of Chronic Hypoxia on the Expression of ATi Receptors 
The mRNA expression of ATi receptors at both ATia and ATib subtypes was 
investigated using RT-PCR in conjunction with specific primers corresponding to their 
respective non-coding sequences. A marked effect of chronic hypoxia on the expression 
of ATia and ATib subtypes was observed in the carotid body, whereas the expression 
levels of p-actin remained unchanged in chronic hypoxia when compared with that in 
controls (Figs. 3-5 and 3-6). There were significant increases in the mRNA expression 
for the ATia subtype (Fig. 3-5A) and for the ATib subtype (Fig. 3-6A) in the chronic 
hypoxia group compared with their respective controls. The relative expression changes 
of ATia subtype (Fig. 3-5B) and ATib subtype (Fig. 3-6B) were about two-fold in both 
subtypes, as demonstrated by RT-PCR and image analysis. 
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Figure 3-5 A. RT-PCR analysis of the mRNA expression of ATia receptor by chronic 
hypoxia in the rat carotid body. Lane M, DNA marker; lane 1, AT!a 
receptor (expected size = 385 bp) expression in normoxic (control) 
carotid bodies; lane 2, ATia receptor expression in hypoxic carotid bodies; 
lane 3, p-actin (expected size = 240 bp) expression in normoxic carotid 
bodies; lane 4，p-actin expression in hypoxic carotid bodies; lane 5，ATia receptor expression in adrenal glands. B. The relative expression of ATia 
receptor/p-actin mRNA (% of control) in the normoxic and chronically 
hypoxic group of carotid bodies. The data are expressed as means 土 S.E.M. (n=5 for each group). •P<0.05. “ 
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Figure 3-6 A. RT-PCR analysis of the mRNA expression of ATib receptor by chronic 
hypoxia in the rat carotid body. Lane M, DNA marker; lane 1，ATib receptor (expected size = 204 bp) expression in normoxic (control) 
carotid bodies; lane 2，ATib receptor expression in hypoxic carotid bodies; 
lane 3，p-actin (expected size = 240 bp) expression in normoxic carotid 
bodies; lane 4，p-actin expression in hypoxic carotid bodies; lane 5, ATib 
receptor expression in adrenal glands. B. The relative expression of ATib 
receptor/p-actin mRNA (% of control) in the normoxic and chronically 
hypoxic group of carotid bodies. The data are expressed as means 土 S.E.M. (n=5 for each group). *P<0.05. _ 
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3.2.2 Effect of Chronic Hypoxia on the Expression of AT2 Receptors 
The mRNA expression of AI2 receptor was also studied in the carotid body using 
RT-PCR in conjunction with specific primers corresponding to their respective non-
coding sequences. Chronic hypoxia had a less prominent effect on the AT2 receptor 
expression, whereas the expression levels of p-actin remained unchanged in chronic 
hypoxia when compared with that in controls (Figs. 3-7A). There was a slight but 
consistent increase of about 15% of the relative expression of AT2 receptor in the 
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Figure 3-7 A. RT-PCR analysis of the mRNA expression of AT: receptor by chronic 
hypoxia in the rat carotid body. Lane M, DNA marker; lane 1, ATia 
receptor (expected size = 511 bp) expression in noraioxic (control) 
carotid bodies; lane 2, AT2 receptor expression in hypoxic carotid bodies; 
lane 3，p-actin (expected size = 240 bp) expression in normoxic carotid 
bodies; lane 4, p-actin expression in hypoxic carotid bodies; lane 5, AT2 
receptor expression in adrenal glands. B. The relative expression of AT2 
receptor/p-actin mRNA (% of control) in the normoxic and chronically 
hypoxic group of carotid bodies. The data are expressed as means 土 S.E.M. (n=5 for each group). *P<0.05. 
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3.2.3 Cellular Localization of the ATi Receptor by Chronic Hypoxia 
To further elucidate the precise localization of ATi receptor expression and its 
upregulation during chronic hypoxia, immunohistochemistry was employed. Results 
from immunohistochemistry showed that there was an increase in the intensity of the 
immunoreactivity for the ATi receptor in chronically hypoxic carotid boy compare with 
control (Fig. 3睡8). Intense immunoreactivity for tyrosine hydroxylase was observed in 
the glomus cells, which was employed as a positive immunohistochemical marker for 
parenchymal type I glomus cells [Kameda et al., 1990]. Tyrosine hydroxylase 
immunoreactivity was more intense in the hypoxic group (Fig. 3-8B) than in noraioxic 
controls (Fig. 3-8A). 
Detailed examination of consecutive sections of carotid body showed that 
distinct but less intense immunoreactivity for ATi receptor was predominantly localized 
to glomus cells in normoxic control (Fig. 3-8C and D) when compared with that in 
chronically hypoxia carotid body, which exhibited very intense immunostaining of ATi 
receptor (Fig. 3-8E and F). Intense immunostaining of ATi receptor was consistently 
observed in glomus cells of chronically hypoxic carotid body with sections 
counterstained with haematoxylin (Fig. 3-8G). 
Specificity of the immunostaining was validated by negative control experiments 
when specific antibody was pre-absorbed in excess with its ATi receptor antigen either 
with counterstaining (Fig. 3-8H) or without counterstaining (Fig. 3-81). 
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Figure 3-8 Immunohistochemical localization of ATi receptor and tyrosine 
hydroxylase proteins in normoxic and chronically hypoxic rat carotid 
body. Distinct immunoreactivity for tyrosine hydroxylase was localized 
to the perinuclear cytoplasm of glomus cells in the carotid body from 
normoxia (A) and chronic hypoxia (B). Less intense immunoreactivity 
for the All receptor was predominantly localized to glomus cells from 
normoxic controls in lower magnification (C) and in high magnification 
(D). Intense immunostaining was consistently localized to glomus cells 
from chronic hypoxia in low magnification (E) and in high magnification 
(F). distinct immunostaining in glomus cells from chronically hypoxic 
carotid body was shown in serial sections counterstained with 
haematoxylin (G). No immunostaining was observed in pre-adsorption 
of primary antibody with excess of ATi receptor antigen either with (H) 
or without (I) counterstaining. Scale bar = 100 jim. 
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3.2.4 Increase of Afferent Nerve Activities of the Carotid Body In-vitro by 
Angiotensin II 
Ang II increased the resting activity of carotid bodies in normoxic and 
chronically hypoxic rats. Figure 3-9 shows that Ang II stimulated the afferent discharge 
of carotid body isolated from a chronically hypoxic rat. The perfusion of Ang II 
increased the basal discharge rate of a single unit (Fig. 3-9A and B). Ang II (0.1-100 
nM) dose-dependently increased afferent discharge of the carotid body. The average 
dosage response to Ang II (100 nM) is 430% in the chronically hypoxia group compared 
with 220% in the normoxic group (Fig. 3-9C). Thus, the response to Ang II was 
enhanced in the chronically hypoxic group and the dosage-response curve for the 
chronically hypoxic group was shifted to the left, suggesting that maximal binding 
capacity for the Ang II was increased in the chronically hypoxic carotid body. 
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Figure 3-9 Ang II increases afferent nerve activities of the carotid body in vitro. A. 
At rest, the carotid body had a low basal activity. B. The activity of the 
carotid body was increased following the perfusion of Ang II (10 nM, 3 
minutes). Scale bars for (A) and (B) are 1.5 seconds. C. The dose-
dependent curves of the stimulatory effect of Ang II on the nerve 
discharge in the normoxic (N, • , n=8) and chronic hypoxia (CH, • , n=8) 
groups. The concentration of Ang II is plotted on a logarithmic scale and 
that the sensitivity for the Ang II response was enhanced in the CH 
groups compared with the normoxic control. The data are expressed as 
means 土 S .RM •Statistical significance when compared with 
corresponding dosage in the normoxic group (P<0.05). 72 
3.2.5 Inhibition of Angiotensin Il-mediated Response in Chronically Hypoxic 
Carotid Body by Losartan 
To determine whether ATi receptors mediate the enhanced response to Ang II， 
the chronically hypoxic carotid body was pretreated with specific antagonist for AT! 
receptor, losartan (10 jxM for 10 minutes), before the perfusion of Ang II (100 nM). The 
response to Ang II was significantly attenuated by the pretreatment of losartan. Figure 
3-10 shows the afferent activities before (A), during (B) and following wash (C) in a 
carotid body. In all chronically hypoxic carotid bodies tested (n=9) losartan reduced the 
response to Ang II (Fig. 3-lOD). Results suggested that AT! receptors mediate the 
enhanced response to Ang II in the chronically hypoxic carotid body. 
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Figure 3-10 The perfusion of Ang II in CH carotid body. A. Perfusion of Ang II (100 
nM, 3 minutes) increased the afferent discharge rate (Hz) of a CH carotid 
body. B. The response to Ang II was attenuated by pretreatment with 
losartan (10 \M, 10 minutes). C. Following wash for 60 minutes, the 
response to Ang II was partially recovered. Scale bars for (A)-(C) are 3 
minutes. D. Summary of the response to Ang II in CH carotid bodies 
before the treatment of losartan (ANG), after the treatment of losartan 
(LOS+ANG) and following wash-out (WASH+ANG). The data are 
expressed as means 土 S.E.M. *Statistical significance when compared 
withANG+LOS (P<0.05). 
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3.3 Evidence for the Existence of an Intrinsic Angiotensin-generating System 
Chronic hypoxia was shown to upregulate the transcriptional and post-
transcriptional expression of ATi receptors in rat carotid body, which in turn enhances 
ATi receptor-mediated excitation of the carotid afferent activity. In spite of this close 
association between the regulation and function of ATi receptor in the carotid body, 
there has been no evidence of the existence for an intrinsic, angiotensin-generating 
system in the carotid body. Therefore，the presence of a local RAS on the rat carotid 
body was to be demonstrated. 
3.3.1 Expression and Localization of Angiotensinogen mRNA 
As the first step to identifying RAS component mRNAs, RT-PCR coupled with 
specific primers for angiotensinogen, the mandatory component of the RAS, was 
performed to see whether it is present in the rat carotid body. Results from RT-PCR 
showed that mRNA of angiotensinogen was expressed in the rat carotid body, although 
its level of expression appeared to be low when compared with that in the liver (Fig. 3-
11). The precise cellular localization and expression of angiotensinogen mRNA in rat 
carotid body was further determined by in-situ hybridization histochemistry. A positive 
signal for angiotensinogen mRNA was detected specifically in clusters of glomus cells 
in rat carotid body using specific antisense riboprobes of angiotensinogen (Fig. 3-12A 
and B). The specificity of the in-situ hybridization was demonstrated by the absence of 
signals in the carotid body sections where a sense riboprobe for angiotensinogen mRNA 
was used (Fig. 3-12C and D). 
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Figure 3-11 RT-PCR analysis of angiotensinogen mRNA in rat carotid body. Lane M, 
DNA marker; Lane 1，angiotensinogen expression in carotid bodies; Lane 2，angiotensinogen expression in liver; Lane 3，P-actin expression in 
carotid bodies; Lane 4, p-actin expression in liver. The expected size of 
PGR products from angiotensinogen is 312 bp and that from p-actin is 
240 bp. 
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Figure 3-12 In-situ hybridization of angiotensinogen mRNA using dioxigenin-labeled 
antisense and sense riboprobes on cryosections of rat carotid body. 
Intense hybridization signals for angiotensinogen mRNA was detected in 
clusters of glomus cells in the carotid body using antisense riboprobes, as 
shown in (A) low magnification (20x) and (B) high magnification (63x). 
No positive hybridization signals for angiotensinogen mRNA was 
detected in the carotid body using sense riboprobes, as shown in (C) low 
magnification (20x) and (D) high magnification (63x). 
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3.3.2 Expression and Localization of Angiotensinogen Protein 
In order to study the expression of the precursor angiotensinogen at the protein 
level, SDS-PAGE and Western blot analysis were preformed on the homogenate of rat 
carotid body. A major protein band of about 60 kDa was apparently expressed in the rat 
carotid body. This molecular mass is in close agreement with that of one of the 
angiotensinogen isoforms purified from plasma of nephrectomized rat [Thomas et al., 
1995; Hilgenfeldt and Hackenthal, 1982], which was used as a positive control in the 
experiment (Fig. 3-13). The precise localization of angiotensinogen was then studied by 
immunohistochemistry using a specific antibody against the purified rat protein. 
Immunohistochemical examination of the rat carotid body showed that 
immimoreactivity for angiotensinogen appeared to be localized exclusively in the cell 
clusters of glomus cells (Fig. 3-14A). In a similar manner, immimoreactivity for 
tyrosine hydroxylase, which was used as a positive immunohistochemical marker for 
parenchymal type I glomus cells [Kameda et al., 1990], was observed in the glomus cell 
as well (Fig. 3-14B). These results were further confirmed by the combined image of 
immunostaining for both angiotensinogen and tyrosine hydroxylase, where co-
localization of immunoreactivities was observed (Fig. 3-14C). These indicated that 
distinct immunostaining of angiotensinogen was predominantly localized to the cell 
clusters of type I glomus cells in rat carotid body. Specificity of the immunostaining 
was validated by the negative control experiments when specific antibody was 
preabsorbed in excess with its angiotensinogen antigen (Fig. 3-14D). 
78 
60 kDa ^ M M I 
• j^^ HHMMHi^ HF 
Ao 1 2 
Figure 3-13 Western blot analysis for angiotensinogen of SDS-PAGE separated 
proteins from homogenates of rat carotid body. Lane Ao shows plasma 
angiotensinogen purified from nephrectomized rat. A major band of 
about 60 kDa was detected. Lane 1 and lane 2 show the expression of 
angiotensinogen protein of carotid bodies at 5 jig and 10 i^g respectively. 
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Figure 3-14 Immunohistochemical localization of angiotensinogen and 
tyrosine hydroxylase in rat carotid body. Distinct 
immunoreactivity for angiotensinogen was localized to the 
perinuclear cytoplasm of glomus cells in the carotid body in (A) 
high magnification (63x) and (D) low magnification (20x). (B) 
Intense immunoreactivity for tyrosine hydroxylase was localized 
to the type I glomus cells of the carotid body. (C) 
Immunoreactivities for angiotensinogen (red in colour) and 
tyrosine hydroxylase (blue in colour) were consistently and 
predominantly co-localized to the glomus cells of the carotid 
body. (E) No immunostaining was observed in preadsorption of 
primary antibody with excess of angiotensinogen antigen. 
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3.3.3 Expression of Renin mRNA 
Although renin is one of the determining enzymes in the conversion of 
angiotensinogen into Ang II, the physiological active component of the RAS, renin 
mRNA was not found to be expressed in rat carotid body by RT-PCR (Fig. 3-15). To 
further confirm this finding, northern blot analysis for the expression of renin mRNA 
was performed. No hybridization signals for renin was detected in rat carotid body, 
whereas a prominent band with molecular mass of 1.6 kb was detected from the kidney 
which was used as the positive control for the northern blot (Fig. 3-16). 
3.3.4 Expression of ACE mRNA 
The mRNA expression of ACE, another major enzyme in the RAS, was also 
studied in rat carotid body. The result from the RT-PCR showed that ACE mRNA was 
found to be expressed in rat carotid body, although its level of expression was lower than 
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Figure 3-15 RT-PCR analysis of renin mRNA in rat carotid body. Lane M, DNA 
marker; Lane 1，renin expression in carotid bodies; Lane 2，renin 
expression in kidney; Lane 3, p-actin expression in carotid bodies; Lane 4，P-actin expression in kidney. The expected size of PGR products from 
renin is 373 bp and that from P-actin is 240 bp. 
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Figure 3-16 Northern blot analysis of the expression of renin mRNA in rat carotid 
body. No hybridization signals for renin was detected in the carotid body 
(Lane Cb) while a prominent band with molecular mass of 1.6 kb was 
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Figure 3-17 RT-PCR analysis of ACE mRNA in rat carotid body. Lane M，DNA 
marker; Lane 1，ACE expression in carotid bodies; Lane 2, ACE 
expression in lung; Lane 3，P-actin expression in carotid bodies; Lane 4， P-actin expression in lung. The expected size of PCR products from ACE 
is 406 bp and that from P-actin is 240 bp. 
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3.4 Effect of Chronic Hypoxia on the Locally-generated Angiotensin System 
A locally angiotensin-generating system was shown to operate in the carotid 
body, which might be linked to a renin-independent biosynthetic pathway. The local 
regulation of which by chronic hypoxia would be important in the pathophysiological 
adaptations of our body. Thus, the effects of chronic hypoxia on the expression and 
localization of Ang II receptors of the carotid body was examined. 
3.4.1 Effect of Chronic Hypoxia on the Expression of Angiotensinogen mRNA 
The mRNA expression of angiotensinogen was investigated using RT-PCR in 
conjunction with specific primers corresponding to their respective non-coding 
sequences. A marked effect of chronic hypoxia on the expression of angiotensinogen 
was observed in the carotid body, whereas the expression levels of P-actin remained 
unchanged in chronic hypoxia when compared with that in controls (Fig. 3-18). There 
were significant increases in the mRNA expression for angiotensinogen (Fig. 3-18A) in 
the chronic hypoxia group compared with their respective controls. The relative 
expression change of angiotensinogen (Fig. 3-18B) was about two-fold, as demonstrated 
by RT-PCR and image analysis. 
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Figure 3-18 A. RT-PCR analysis of the mRNA expression of angiotensinogen by 
chronic hypoxia in the rat carotid body. Lane M, DNA marker; Lane 1, 
angiotensinogen (expected size = 312 bp) expression in normoxic 
(control) carotid bodies; Lane 2, angiotensinogen expression in hypoxic 
carotid bodies; Lane 3，p-actin (expected size = 240 bp) expression in 
normoxic carotid bodies; Lane 4’ p-actin expression in hypoxic carotid 
bodies; Lane 5, angiotensinogen expression in liver. B. The relative 
expression of angiotensinogen/p-actin mRNA (% of control) in the 
normoxic and chronically hypoxic group of carotid bodies. The data are 
expressed as means 土 S.E.M. (n=5 for each group). •P<0.05. 
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3.4.2 Effect of Chronic Hypoxia on the Localization of Angiotensinogen mRNA 
To further elucidate the precise cellular localization of angiotensinogen mRNA 
expression and its upregulation during chronic hypoxia, in-situ hybridization 
histochemistry was employed. A positive signal for angiotensinogen mRNA was 
detected specifically in clusters of glomus cells in rat carotid body using specific 
antisense riboprobes of angiotensinogen in both the chronically hypoxia and the 
normoxic carotid body (Fig. 3-19). 
Results from in-situ hybridization showed that there was an increase in the 
mRNA expression of angiotensinogen in chronically hypoxic carotid body at low 
magnification (Fig. 3-19A) and high magnification (Fig. 3-19C) when compare with 
normoxic control at low magnification (Fig. 3-19B) and high magnification (Fig. 3-
19D). The specificity of the in-situ hybridization was demonstrated by the absence of 
signals in the carotid body sections where a sense riboprobe for angiotensinogen mRNA 
was used (Fig. 3-19E and F). 
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Figure 3-19 In-situ hybridization of angiotensinogen mRNA using dioxigenin-labeled 
antisense and sense riboprobes on cryosections of rat carotid body. 
Intense hybridization signals for angiotensinogen mRNA was detected in 
clusters of glomus cells in the chronically hypoxic carotid body using 
antisense riboprobes, as shown in (A) low magnification (20x) and (C) 
high magnification (63x). Less intense hybridization signals for 
angiotensinogen mRNA was detected in the normoxic (control) carotid 
body was shown in (B) low mapification (20x) and (D) high 
magnification (63x). No positive hybridization signals for 
angiotensinogen mRNA was detected in the carotid body using sense 
riboprobes, as shown in (C) low magnification (20x) and (D) high 
magnification (63x). 
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3.4.3 Effect of Chronic Hypoxia on the Expression of Angiotensinogen Protein 
The expression change of angiotensinogen protein by chronic hypoxia was 
investigated by Western blot analysis. A predominant band of about 60 kDa was 
consistently detected in both normoxic and hypoxic rat carotid bodies (Fig. 3-20A). The 
specificity of the antibody was validated as the antibody detected a band, which had a 
similar molecular size with that of angiotensinogen isoforms purified from the 
nephretomized rat plasma [Thomas et al., 1995; Hilgenfeldt and Hackenthal, 1982]. 
Under hypoxic treatment, angiotensinogen protein expression was found to be increased 
significantly when compared to that of normoxic control. There was a slight but 
consistent increase of about 15% of the relative expression of angiotensinogen protein in 
the chronically hypoxic group (Fig. 3-20B), as demonstrated by image analysis. 
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Figure 3-20 A. Western blot analysis of angiotensinogen protein (5 |Lig) expression by 
chronic hypoxia in rat carotid bodies. Lane Ao, plasma angiotensinogen 
purified from the nephrectomized rat. A major band of 60 kDa was 
detected; Lane C, angiotensinogen expression in normoxic rat carotid 
bodies; Lane H, angiotensinogen expression in hypoxic rat carotid bodies. 
B. The relative expression of angiotensinogen protein in the normoxic 
and chronically hypoxic group of carotid bodies. The data are expressed 
as means 土 S.E.M. (n=5 for each group). *P<0.05. 
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3.4.4 Effect of Chronic Hypoxia on the Expression of ACE 
Provided the fact that ACE is one of the crucial enzymes of RAS and it is found 
to be produced locally in rat carotid body. The mRNA expression of ACE was 
investigated using RT-PCR in conjunction with specific primers corresponding to their 
respective non-coding sequences. A significant effect of chronic hypoxia on the 
expression of ACE was observed in the carotid body, whereas the expression levels of P-
actin remained unchanged in chronic hypoxia when compared with that in controls (Fig. 
3-21). There were significant increases in the mRNA expression for ACE (Fig. 3-21 A) 
in the chronic hypoxia group when compared with their respective controls. A slight but 
consistent increase of about 10% of the relative expression of ACE mRNA in the 
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Figure 3-21 A. RT-PCR analysis of the mRNA expression of ACE by chronic hypoxia 
in the rat carotid body. Lane M, DNA marker; lane 1，ACE (expected 
size = 406 bp) expression in normoxic (control) carotid bodies; lane 2, 
ACE expression in hypoxic carotid bodies; lane 3, p-actin (expected size 
= 2 4 0 bp) expression in normoxic carotid bodies; lane 4, p-actin 
expression in hypoxic carotid bodies; lane 5，ACE expression in lung. B. 
The relative expression of ACE/p-actin mRNA (% of control) in the 
normoxic and chronically hypoxic group of carotid bodies. The data are 
expressed as means 土 S.E.M. (n=5 for each group). •P<0.05. 
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3.5 Time-course Effect of Chronic Hypoxia on ACE Activity 
The expression of ACE protein in chronic hypoxia was investigated using 
specific assay for ACE activity. The effects of chronic hypoxia on ACE expression were 
tested in a time dependent manner with 7-, 14- and 28-day hypoxia. The activities of 
ACE were shown in nmol/^g/min x 10"^  unit and lung was used as a positive control as 
it is the major site where ACE is being produced. Samples with the addition of 15|uM 
captopril (a specific ACE inhibitor) were used as the negative control as the activities of 
ACE could be blocked and the reading should be more or less close to zero. 
In general, ACE activity of rat carotid bodies was shown to be increased by 
chronic hypoxia treatment of 7，14 and 28 days (Fig. 3-22). There was a 2.06, 3.47 and 
1.86 times increase in the ACE activities in 7-, 14- and 28 day hypoxia rat carotid bodies 
when compared to those of their controls respectively (Table 3-1). 
The activities of ACE in the 7-day (Fig. 3-23) and the 14-day hypoxia rat carotid 
bodies (Fig. 3-24) were shown to be significantly different from their respective 
normoxic controls, whereas the 28-day hypoxic rat carotid bodies were not different 
from their normoxic controls (Fig. 2-25). No ACE activity was found in the captopril-
added positive controls for all of the samples tested (Fig. 3-23,3-24 and 3-25). 
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Table 3-1 Changes of ACE activities in chronic hypoxia on rat carotid bodies in a 
time dependent manner. 
Activity of ACE (nmol/^g/min) x 10"^  RATI(5 
15.00 30.95 2.06 
< J i 30.25 “ 3.47 
° 1118 24.53 
Normoxia Hypoxia  
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Figure 3-22 Time-course effect of chronic hypoxia on ACE activity of rat carotid 
bodies. Relative ACE activity expressed in nmol/jLig/min of hypoxic 
mature rat carotid bodies was compared with that in normoxic rat carotid 
bodies. NN7cb, ACE activity in 7-day normoxic rat carotid bodies; 
NN14cb，ACE activity in 14-day normoxic rat carotid bodies; NN28cb', 
ACE activity in 28-day normoxic rat carotid bodies; N07cb, ACE 
activity in 7-day hypoxic rat carotid bodies; N014cb, ACE activity in 14-
day hypoxic rat carotid bodies; N028cb, ACE activity in 28-day hypoxic 
rat carotid bodies. The data are expressed as means 土 S.E.M. (n=5 for each group). 一 
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Figure 3-23 Effect of chronic hypoxia (7 days) on ACE activity of rat carotid bodies. 
Relative ACE activity expressed in nmol/ng/min of 7-day hypoxic mature 
rat was compared with that in normoxic rat carotid bodies. NN7cb, ACE 
activity in 7-day normoxic rat carotid bodies; N07cb, ACE activity in 7-
day hypoxic rat carotid bodies; Lung, ACE activity in lung; NN-inhibitor, 
ACE activity with ACE inhibitor in 7-day hypoxic rat carotid bodies; 
No-inhibitor, ACE activity with ACE inhibitor in 7-day hypoxic rat 
carotid bodies; L-inhibitor, ACE activity with ACE inhibitor in lung. The 
data are expressed as means 土 S.E.M. (n=5 for each group). »*Statistical 
significance when compared with the normoxic group (P<0.05). 
•Statistical significance when compared with activity in corresponding 
group without application of inhibitor (P<0.05). 
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Figure 3-24 Effect of chronic hypoxia (14 days) on ACE activity of rat carotid bodies. 
Relative ACE activity expressed in nmol/^g/min of 14-day hypoxic 
mature rat carotid bodies was compared with that in normoxic rat carotid 
bodies. NN14cb, ACE activity in 14-day normoxic rat carotid bodies; 
N014cb, ACE activity in 14-day hypoxic rat carotid bodies; Lung, ACE 
activity in lung; NN-inhibitor, ACE activity with ACE inhibitor in 14-day 
hypoxic rat carotid bodies; NO-inhibitor, ACE activity with ACE 
inhibitor in 14-day hypoxic rat carotid bodies; L-inhibitor, ACE activity 
with ACE inhibitor in lung. The data are expressed as mean 土 S.E.M. (n=5 for each group). *• Statistical significance when comparecTwith the 
normoxic group (P<0.05). ^Statistical significance when compared with 
activity in corresponding group without application of inhibitor (P<0.05). 
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Figure 3-25 Effect of chronic hypoxia (28 days) on ACE activity of rat carotid bodies. 
Relative ACE activity expressed in nmol/^g/min of 28-day hypoxic 
mature rat carotid bodies was compared with that in normoxic rat carotid 
bodies. NN28cb，ACE activity in 14-day normoxic rat carotid bodies. 
N028cb, ACE activity 
in 28-day hypoxic rat carotid bodies. Lung ACE 
activity in lung; NN-inhibitor, ACE activity with ACE inhibitor in 28-day 
hypoxic rat carotid bodies; NO-inhibitor, ACE activity with ACE 
inhibitor in 28-day hypoxic rat carotid bodies; L-inhibitor, ACE activity 
with ACE inhibitor in lung. The data are expressed as mean 土 S.E.M. (n=5 for each group). •Statistical significance when compared with 
activity in corresponding group without application of inhibitor (P<0.05). 
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3.6 Preliminary Studies of AT4 Receptor 
There is now mounting evidence suggesting that Ang IV, a hexapeptide fragment 
derived from Ang II, can produce a receptor mediated biological response. Ang IV has 
been shown to preferentially bind to the AT* receptors that have been shown to be 
heavily distributed in a variety of tissues such as the lung and kidney. However, the 
distribution and cellular localization of this receptor in the rat carotid body are largely 
unidentified. 
3.6.1 In-vitro Autoradiographic Study of AT4 Receptors 
Figure 3-26 shows AT4 receptor binding in rat kidney and carotid body by in 
autoradiography using '^^I-Ang IV. In kidney, ^^^I-Ang IV appeared to bind with 
high intensity to the entire cortex, with no visible binding in the medulla (Fig. 3-26A). 
Non-specific binding, as determined in the presence of an excess of imlabelled Ang IV 
(10-5 j^，was almost undetectable (Fig. 3-26B). The specificity of the ^^ I^-Ang IV was 
demonstrated in the presence of an excess of Sarile ([Sar^Ile^]Ang II; 10"^  M), an Ang II 
antagonist, in which ^^^I-Ang IV appeared to bind with high intensity to the entire 
cortex, with no visible binding in the medulla (Fig. 3-26C). 
In a coarse manner, the carotid body shows similar binding pattern of ^^^I-Ang 
IV to its AT4 receptors as the kidney. There was a high density of ^^^I-Ang IV binding 
localized over the entire carotid body (Fig. 3-26D). The ^^^I-Ang IV binding was 
displaced by excess amount of unlabeled Ang IV (Fig. 3-26E) but not by excess amount 
of Sarile (Fig. 3-26F). 
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Figure 3-26 In vitro autoradiographic localization of AT4 receptor sites in rat kidney 
and carotid body. Panels on top show total ^^ I^-Ang IV binding (A), + 如g l y (B), + Sarile (C) in rat kidneys (arrows). Panels at bottom show 
total I-Ang IV binding (D), + Ang IV (E)，+ Sarile (F) in rat carotid bodies (triangles). Concentration of ^^^I-Ang IV, unlabeled Ang IV and Sarile were 100,000cpm/ml, 10"^  MandlO"^M respectively. 
99 
3.6.2 Localization of AT4 Receptors 
To further elucidate the microscopic localization of AT4 receptor in the rat carotid 
body and kidney, a non-radioactive binding assay of FITC-conjugated Ang IV was used. 
FITC-Iabeled Ang IV appeared to bind with high intensity to kidney, which was used as 
a positive control (Fig. 3-27G). Non-specific binding, as determined in the presence of 
an excess of unlabeled Ang IV (10'^ M), was almost undetectable (Fig. 3-27H). The 
specificity of the ^^ I^-Ang IV was demonstrated in the presence of an excess of Sarile 
(10"^  M), in which ^^ I^-Ang IV appeared to bind with high intensity to the kidney as well 
(Fig. 3-271). 
The carotid body shows similar binding pattern of FITC-labeled Ang IV to its 
AT4 receptors as the kidney. There was a high intensity of FITC-labeled Ang IV binding 
localized probably to the glomus cells of the carotid bodies. More intense binding was 
detected in the glomus cells in chronically hypoxic group when compared with that in 
respective normoxic control (Fig. 3-27A and D). Similarly, the FITC-labeled Ang IV 
binding was displaced by excess amount of unlabeled Ang IV (Fig. 3-26B and E) but not 
by excess amount of Sarile (Fig. 3-26C and F) in both the chronically hypoxic group and 
its normoxic controls. 
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Figure 3-27 Microscopic localization of AT4 receptor sites in normoxic and 
chronically hypoxic rat carotid body. Panels on top show FITC-coupled 
^ g IV binding (A), + Ang IV (B), + Sarile (C) in normoxic rat carotid 
body. Panels m the middle show FITC-coupled Ang IV binding (D) + 
Ang IV (E), + Sarile (F) in chronically hypoxic rat carotid body Panels 
at bottom show FITC-coupled Ang IV binding (D), + Ang IV (E) + 
Sarile (F) in rat kidney, which was used as the positive confrol 
Concentration of FITC-coupled Ang IV’ unlabeled Ang IV and Sarile 
were 200nM, lO'' M and 10石 M respectively. Magnification x 63. 
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Chapter 4 Discussion 
4.1 Functional Expression of Angiotensin II Receptors 
The hypothesis that Ang II receptors are expressed functionally in the Type I cell 
of the carotid body is supported by the findings that � Ang II increases [Ca2+]i in Type I 
cells of the rat carotid body; (2) Gene transcripts ofATi receptor subtypes, ATia and ATib, 
are expressed in the rat carotid body; and (3) ATi receptors are localized in the lobules of 
Type I cells. The [Ca^^i response to Ang II was blocked by losartan, an ATi antagonist, 
but not by PD123319, an AT2 antagonist. It suggests that Ang II binding to ATi 
receptors stimulates the intracellular signaling pathway and elevates the in the 
Type I cells, which may, in turn, increase afferent discharge of the carotid body. The 
changes may contribute to the cardiorespiratory responses to physiological stimulation. 
Among all the tested clusters of the Type I cells in the carotid body, the [Ca^^Ji 
response to Ang II was seen only in 38% of the cell clusters (Section 3.1.1). This 
subpopulation of Type I cells which express the AT! receptor，may be explained by the 
high variability in the magnitude of the multi-unit responses to Ang II as reported 
previously using electrophysiological study [Allen, 1998]. In the same manner, the Type 
I cells of the carotid body also showed heterogeneous responses to acetylcholine. It was 
reported that acetylcholine increases [ C a � � i n 55% of Type I cells and that the responses 
to nicotinic and muscarinic stimulation are different [Dasso et al.，1996]. However, the 
functional significance of the phenotypic heterogeneity of the Type I cells remains 
unknown. 
It is shown from the results that the [Ca'^i response is specific to the activation 
of Ang II receptors because the [ C a � ] response to Ang II was abolished by losartan (a 
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specific ATI receptors antagonist) pretreatment but not by PD123319 (a specific AT2 
receptors antagonists) pretreatment (Section 3.1.2; Fig. 3-2). The response was 
only slightly decreased by PD123319，an AT2 receptor antagonist, and was not changed 
by vehicle treatment. These results strongly suggest that elevation in Type I cells 
of rat carotid body is mediated by the activation of the ATj receptors, but not the AT2 
receptors. Moreover, the [Ca2+]i response to Ang II was relatively small compared with 
the response to cyanide, which is consistent with the electrophysiological finding that 
the increased afferent discharge induced by Ang II is less than that induced by hypoxia 
[Allen, 1998]. 
In response to Ang II，the elevation was found in all of the responsive 
clusters of the Type I cells in the carotid body suggesting that the [Ca^'li elevation is 
involved in the increase of chemoreceptor afferent activity. This is matched with the 
previous finding that [Ca2+]i elevation is critical for Type I cell secretion and 
chemotransduction [Biscoe et al., 1989; Buckler and Vaughan-Jones, 1994]. The 
activation of these G-protein coupled ATi receptors may lead to the release of 
intracellular C a � . via the IP3 pathway [Balla et al., 1989; Balla et al., 1991] although 
details of the signaling pathway for their activation is still to be investigated. 
While Ang II receptors are expressed in various cell types such as the vascular 
endothelium [Barker et al., 1995] and the pancreas [Leung et al.，1997; Leung et al.， 
1998]，mRNA expression of the Ang II receptor in the carotid body was unidentified. 
There are two known subtypes of the AT, receptor expressed in the rat in a tissue-
specific manner [Kakar and Neill, 1993]. From the transcriptional study of the ATi 
receptors in rat carotid body by RT-PCR, it was found that both ATia and ATib receptors 
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are present. This finding supports the previous autoradiographic study that a large 
number of ATj receptors are present in the carotid body [Allen, 1998]. Although the 
functional difference between ATia and ATib receptors is unknown and pharmacological 
tools are not yet able to distinguish between them, ATi receptor subtypes may play 
different physiological roles in the carotid body. 
The localization of the ATi receptor expression was determined by using the 
immunohistochemical study since any functional implications might require information 
on the fine detail of such localization (Section 3.1.4; Fig. 3-4). In this regard, ATj-
immunoreactivity was found to be localized in lobules of the carotid body, suggesting 
that ATi receptors are expressed in the Type I cell. This finding also supports 
autoradiographic study that ATi receptors are intrinsic to the Type I cells [Allen, 1998]. 
Furthermore, ATi immunoreactivity was found to be scattered in the lobules of Type I 
cells，which is consistent with the findings in functional study that ATi receptors were 
expressed in a subpopulation of the Type I cells. 
These results suggest that the carotid body directly responds to circulating Ang II 
and thus induces carotid chemoreceptor afferent activity which activates the neuronal 
regulation of ventilatory and cardiovascular function. The increased carotid 
chemoreceptor activity elevates renal sympathetic activity and this increases renin 
secretion by the juxtaglomerular cells in the kidney would further activate the renin-
angiotensin system to increase sodium reabsorption and water intake [Honig, 1989]. 
Hence, in addition to Ang Il-sensitive neurons in the circumventricular organs of the 
brain [Anthes et al., 1997], circulating Ang II may also excite peripheral chemoreceptors 
that in turn elicit cardiorespiratory changes and facilitate salt and water balance. 
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In summary, it is demonstrated from these results that there are functional 
expression of ATj receptors in the Type I cells of the rat carotid body. Ang II binding to 
the ATi receptors elevates activity of the Type I cells and the increased [Ca2+]i 
activity may modulate carotid body function. 
4.2 Upregulation and Function of Angiotensin II Receptors 
Although some previous studies had reported that plasma Ang II concentrations 
do not increase during acute hypoxia [Davidson and Stalcup, 1984; Maktabi et al , 1994]， 
other studies claimed that hypoxia has an effect on the expression of the circulating RAS. 
It was reported that hypoxia decreased the level of expression of Ang II receptors in 
systemic circulation [Jin et al.，1987]. While in dogs, circulating RAS was shown to be 
directly inhibited by acute hypoxia in one study [Krebs et al, 1999] but was enhanced in 
another study [Liang and Gavras, 1978]. Therefore, the expression characteristics of 
circulating RAS during chronic hypoxia are worth investigating. Interestingly, the 
activation of circulating RAS by chronic hypoxia was associated with a parallel 
upregulation of local RAS components including Ang II receptors in the pancreas [Ip et 
al.，2002]. As there is functional expression of Ang II ATi receptors found in the rat 
carotid body (Section 3.1), the interest was then focused on the effect of chronic hypoxia 
on the expression and function of ATi receptor in the rat carotid body. 
It was clearly demonstrated from the results that there was an upregulation of the 
expression and function of Ang II receptor by chronic hypoxia in rat carotid body 
(Section 3.2). As shown by RT-PCR analysis, chronic hypoxia caused a marked increase 
in the expression of both ATi and AT2 receptors, notably ATi receptor. Results from RT-
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PCR also showed that chronic hypoxia significantly upregulates both mRNA expression 
for ATia and AT^ subtypes (Section 3.2.1 and Section 3.2.2). In parallel with the 
transcriptional level, the ATi receptor was enhanced in the post-transcriptional 
expression. From immimohistochemical studies that expression of the ATj receptor 
protein was specifically localized to the glomus cells of the carotid body and was 
upregulated by chronic hypoxia (Section 3.2.3). In addition，in-vitro 
electrophysiological study coupled with a specific antagonist for ATi receptor further 
confirmed that the upregulation was associated with the increased excitatory response to 
Ang II during chronic hypoxia (Section 3.2.4 and Section 3.2.5). Collectively, these 
results suggest that there was an increase in functional ATj receptors in the carotid body 
during stress of chronic hypoxia. 
Previous studies showed that chronic hypoxia upregulates the expression of RAS 
in a number of tissues, including the kidney [Neylon et al.，1996], the lung [Zhao et al., 
1996a]，the heart [Morrell et al, 1997] and the pancreas [Chan et al., 2000]. In the 
carotid body, the present study has provided unequivocal evidence for the expression of 
both ATi and AT� receptors in the carotid body. Furthermore, the data show that the 
expression of the ATj receptors was subjected to the regulation by chronic hypoxia. The 
upregulation was prominent in the ATi but not ATz subtype, indicating a subtype-specific 
regulation by chronic hypoxia. However, the major upregulation in chronically hypoxic 
rat pancreas is the AT2 subtype [Chan et al., 2000]. Yet the relative importance of the 
subtypes for the ATj receptor is currently unknown [Matsubara et a l , 1994] and the 
signaling mechanisms of the two subtypes are different [Tian et a l , 1996]. Their 
functional roles and upregulation in the carotid body remain to be elucidated. 
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Our results showed that the localization of the expression of ATi receptors in the 
carotid body is mainly found in the Type I glomus cells (Section 3.1.4). It is known that 
ATi receptor may express in the pre-synaptic terminals of sympathetic innervation 
[Castren et al., 1987]. In conjunction with previous finding that sympathetic denervation 
does not change the Ang II binding in the carotid body [Allen, 1998], the sympathetic 
ATi receptors, if any，would be in small amount in the carotid body. Glomus cells are 
believed to be the chemoreceptors and are the catecholamine-containing cells for the 
secretion of catecholamines during hypoxia [Fidone et al.，1982]. In chronic hypoxia, 
the enzyme activity and the gene expression of the tyrosine hydroxylase increase, which 
in turn leads to an increase in the production of catecholamine in the carotid body 
[Donnelly, 1993]. From the resultant data, an enhancement in the tyrosine hydroxylase-
immunoreactivity was shown in the glomus cells with chronic hypoxia (Section 3.2.3; 
Fig. 3-8 A and B). The upregulation of gene expression of the ATi receptor was also 
observed and the intensity of ATi -immunoreactivity was higher in the chronically 
hypoxic group than in the normoxic control (Section 3.2.3; Fig. 3-8 C, D, E and F). 
These findings suggest that chemoreceptors increase the density of ftmctional ATi 
receptors of rat carotid body under stress of chronic hypoxia. 
By using in-vitro electrophysiological studies, it was found that Ang II increased 
afferent discharge of the carotid body (Section 3.2.4). This finding is consistent with a 
previous report that Ang II stimulated carotid chemoreceptor activity [Allen, 1998]. It 
was shown that chronic hypoxia had an excitatory response to Ang II in the carotid body 
as a leftward shift was observed on the dose-response curve (Fig. 3-9). This suggests 
that the affinity to Ang II binding or the receptor density is enhanced in the chronic 
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hypoxia group and is further supported by the fact that the gene expression of the ATi 
receptor in the carotid body was increased in chronic hypoxia. In addition, the response 
to Ang II is inhibited by losartan, a specific antagonist for ATi receptor (Section 3.2.5). 
This finding suggests that the response to Ang II was mediated by the AT] receptor, 
which is upregulated in the carotid body during chronic hypoxia. This is consistent with 
previous finding that the ATi receptor is the major subtype in the carotid body, which 
mediates the carotid body response to Ang II in normoxic rats [Allen, 1998]. Therefore, 
the upregulation of ATi receptors elevates the sensitivity and physiological response of 
the carotid body to Ang II stimulation. Nevertheless, the mechanism underlying the 
upregulation of the AT! receptor in chronic hypoxia remains undefined and yet to be 
investigated. 
In summary, the resultant data suggest that chronic hypoxia could upregulate the 
expression of Ang II receptors, predominantly the ATi receptor, which might result in 
enhancing the carotid afferent nerve activity to Ang II stimulation. This chould, in turn, 
increase the cardiorespiratory response and regulate the salt and water homeostasis 
during stress of chronic hypoxia. 
4.3 Existence of a Local RAS 
The biosynthetic pathway of the circulating RAS consists of the hepatic 
angiotensinogen, which is hydrolyzed by the enzyme renin in the kidney. The resultant 
angiotensin I is subsequently converted to angiotensin II by the membrane-bound 
enzyme ACE in the lung. The circulating angiotensin II exerts the physiological action 
via its specific receptors [De Gasparo et al., 2000]. Apart from the classical circulating 
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RAS, there is increasing evidence suggesting the importance of a local RAS for an 
individual tissue/organ. In this regard, this concept has been under extensive revision 
with the recent demonstration of locally generated angiotensin systems in multiple 
tissues/organs [Campbell, 1987; Phillips et al., 1993]. 
It is better to describe the RAS as an angiotensin-generating system, which 
consists of its obligatory components including angiotensinogen, angiotensins and their 
specific receptors. In addition，it may contain the alternative or non-exclusive 
components including renin, ACE and their functional homologous enzymes [Semia, 
2001]. In fact, a number of alternative enzymes such as tonin [Boucher et al.，1997], 
cathepsin G [Toimesen et al , 1982], trypsin [Arakawa et al., 1980] and kallikrein 
[Manila and Arakawa, 1983] can result in direct generation of angiotensins rather than 
the definitive enzymatic cascade of renin and ACE arising from the classical RAS. One 
of these examples has been best demonstrated by vascular angiotensin-generating 
pathway, where renin-like enzymes were identified in large and small vasculature [Dzau, 
1986; Rosenthal et al., 1984]. This vascular RAS is responsible for producing arteriolar 
constriction and affecting the compliance of large conduit arteries [Dzau, 1987]. 
Interestingly, a local RAS with the absence of renin has been demonstrated in the 
epididymis, which may have a role in the regulation of the epididymal and sperm 
function [Leung et al.，1997; Leung et al., 1999]. However, a local pancreatic RAS 
appears to posses the complete elements including renin necessary for a classical RAS 
[Leung et a l , 1999] and such a local RAS may play a regulatory role in tissue functions 
such as controlling the rate of pancreatic blood flow and islet hormonal secretion in an 
autocrine or paracrine manner [Leung and Carlsson, 2001]. In the carotid body, a local 
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RAS may play an important role in the regulation of the physiological and 
pathophysiological functions in the body. Nevertheless, the existence of such a local 
RAS in the carotid body is not confirmed, meriting further investigation. 
The expression and localization of angiotensinogen, the indispensable 
component for the existence of a locally generated angiotensin system, were clearly 
demonstrated in the rat carotid body. RT-PCR showed that angiotensinogen mRNA was 
expressed in the rat carotid body (Section 3.3.1; Fig. 3-11). In-situ hybridization 
demonstrated the precise localization of angiotensinogen mRNA to the clusters of 
glomus cells in the carotid body (Section 3.3.1; Fig. 3-12). Consistently, Western blot 
analysis and immunohistochemistry demonstrated the expression and localization of 
angiotensinogen protein in the carotid body (Section 3.3.2; Fig. 3-13). Double 
immunostaining technique further demonstrated that angiotensinogen immunoreactivity 
was specifically localized to the type I cells of the carotid body (Section 3.3.2; Fig. 3-14). 
However, renin mRNA could not be detected while ACE mRNA was expressed in the 
carotid body (Section 3.3.3 and Section 3.3.4). These findings suggest that the rat 
carotid body has its own intrinsic, angiotensin-generating system probably via a renin-
independent enzymatic pathway, which is different from the classical concept of 
circulating RAS. 
In the carotid body, it has been shown from the results that functional expression 
of ATi receptor can mediate the intracellular calcium release and thus regulating the 
neural activity of the carotid body chemoreceptor (Section 3.1). Moreover，chronic 
hypoxia upregulates the expression of ATi receptors, leading to an increase of carotid 
afferent nerve sensitivity to angiotensin II stimulation (Section 3.2). Recently, our 
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laboratory have demonstrated that postnatal hypoxia upregulates ATia receptors which in 
turn mediate intracellular calcium activity of the chemreceptors in the carotid body and 
hence modulates the cardiopulmonary functions [Fung et al., 2002]. Interestingly, recent 
findings have demonstrated that ACE genotype-dependent modulation might provide a 
mechanism for respiratory drive in elite endurance performance among high-altitude 
mountaineers [Montgomery et al.，1998; Williams et al , 2000]. To this end, oxygen 
deprivation at altitudes is sensed by carotid bodies, which contain hypoxia-sensitive ATi 
receptors, so as to drive an increase in pulmonary ventilation. Accordingly, it is of great 
interest to elucidate the potential presence of an intrinsic RAS in the carotid body and its 
biosynthetic pathway, which may be important in regulating the carotid body function. 
The results from RT-PCR have shown that angiotensinogen and ACE were 
present while renin was absent in the carotid body. These data indicates that a local 
angiotensin system could exist in the carotid body. The local angiotensins could be 
generated by the action of intracellular renin-like enzymes such as tonin [Boucher et al., 
1997]，cathepsin G [Tonnesen et al., 1982], trypsin [Arakawa et al.，1980], and kallikrein 
[Manita and Arakawa, 1983] on the locally produced angiotensinogen within the carotid 
body. Alternatively, local angiotensins could also be generated by the action of plasma-
derived renal renin on the intracellular or plasma-derived hepatic angiotensinogen, 
followed by the action of tissue ACE within the carotid body. However, the relative 
importance of locally generated renin-like enzymes, angiotensinogen and ACE, and of 
circulating renin and angiotensinogen in the carotid body has yet to be determined. 
Further investigations are needed to confirm the biosynthetic enzymatic pathway, which 
could be operated in the carotid body. 
I l l 
In summary, these data provide evidence for a locally generated angiotensin 
system in the carotid body. Such an intrinsic, angiotensin-generating system should be 
important in the modulation of carotid body function and adaptation in the hypoxic 
ventilatory response and in the electrolyte and water homeostasis during chronic hypoxia. 
4.4 Regulation of the Local RAS 
The existence of an intrinsic angiotensin-generating system in the rat carotid 
body has been discussed in the previous section. Expression of local RAS has been 
shown to be affected by a number of factors such as particular hormone status. For 
example, mRNA expression of angiotensinogen in the rat liver, aorta and kidney was 
enhanced by estrogen whereas no significant effect of which was found in atrium 
[Gordon et al., 1992]. ACTH treatment in rats caused a decrease in AT2 receptor binding 
ability in rat adrenal gland, probably due to a decrease in the mRNA expression of the 
AT2 receptors [Kitamura et al.，1998]. In addition，local RAS has also been reported to 
be modulated by various forms of hypoxic stress. 
Chronic hypoxia was shown to activate the local RAS in a number of tissues 
such as the renal RAS [Neylon et al., 1996; Fletcher et al., 1999], lung RAS [Morrell et 
al.，1995a; Morrell et al , 1995b; Zhao et a l , 1996a]，cardiac RAS [Morrell et a l , 1997] 
and pancreatic RAS [Chan et al.，2000]. Among those reports, hypoxic hypertension 
caused lung vessel muscularization associated with local RAS activation [Chassagne et 
al., 2000]. However, epididymal RAS was shown to be depressed by chronic hypoxia 
[Leung et al., 2001a]. These findings suggested the differential effect of hypoxic stress 
on the regulation of tissue RAS and the modulation of RAS components by chronic 
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hypoxia may be important in the physiology and pathophysiology of the tissue function. 
Accordingly, it is speculated that chronic hypoxia may also play an important roles in 
the modulation of the carotid body function, which may in turn affect physiological and 
pathophysiological adaptation. Thus it would be of interest to elucidate the effect of 
chronic hypoxia on the regulation of the intrinsic angiotensin-generating RAS of the 
carotid body. 
From the results, the major components of the intrinsic angiotensin-generating 
RAS in the carotid body, including angiotensinogen, Ang II receptors and ACE were 
studied and all of them were shown to be upregulated after exposure to chronic hypoxia 
(Section 3.4). It was clearly demonstrated from the results that there was an 
upregulation of the expression of angiotensinogen, the mandatory component of the 
intrinsic angiotensin-generating system, by chronic hypoxia in rat carotid body. As 
shown by RT-PCR analysis, chronic hypoxia caused a significant increase in the 
expression of angiotensinogen mRNA (Section 3.4.1; Fig. 3-18). As demonstrated by 
in-situ hybridization, the mRNA expression for angiotensinogen was specifically 
localized to the glomus cells of the carotid body with much intense hybridization signals 
detected in the chronic hypoxic group when compared with the normoxic control 
(Section 3.4.2; Fig. 3-19). In parallel with the transcriptional level, angiotensinogen was 
also enhanced in the post-transcriptional expression. Consistently, Western blot analysis 
showed that the angiotensinogen protein was upregulated by chronic hypoxia (Section 
3.4.3; Fig. 3-20). In addition, mRNA expression of ACE, which was shown to be 
produced locally in the carotid body, was also upregulated by chronic hypoxia as 
demonstrated by RT-PCR (Section 3.4.4; Fig. 3-21). Taken together, chronic hypoxia 
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could activate the local components of the intrinsic angiotensin-generating system in the 
rat carotid body. 
As angiotensinogen is the only primary precursor of the physiologically active 
Ang II，increased mRNA expression of angiotensinogen may imply the increased 
production of Ang II in chronic hypoxic environment. Increased level of Ang II together 
with increased expression of its two receptors, ATi and AT:，may therefore enhance the 
action of Ang II through the mediation of its receptors. RAS is well known for its 
vasoconstrictor action and stimulation of hormone secretion and ion transport [Peach, 
1977]’ therefore the prominent increase of the level of mRNA expression of 
angiotensinogen, ACE and functional Ang II receptor subtypes in the rat carotid body 
may contribute an further enhancement in the carotid afferent nerve activity to Ang II 
stimulation. This could, in turn, increase the cardiorespiratory response and regulate the 
salt and water homeostasis during the stress of chronic hypoxia. 
Airway neuroepithelial bodies sense changes in inspired O2, whereas arterial O2 
levels are monitored primarily by the carotid body. Both respond to hypoxia by 
initiating corrective cardiorespiratory reflexes, thereby optimizing gas exchange in the 
face of a potentially deleterious O2 supply [Peers and Kemp, 2001]. During chronic 
hypoxia, the oxygen supply to the tissues is limited. Some of vital organs such as the 
brain and the heart require constant supply of oxygen for their normal physiological 
functions. The stimulation of the carotid body chemoreceptors by chronic hypoxia 
would lead to an increase in the sympathetic outflow, and thus acutely increasing blood 
pressure. Carotid body denervation, sympathetic nerve ablation, renal sympathectomy, 
adrenal medullectomy, and Ang II receptor blockade are known factors that block blood 
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pressure increase. It appears that adrenergic and RAS overeactivity contributes to the 
early chronic elevated blood pressure in rat intermittent hypoxia and perhaps to human 
hypertension associated with obstructive sleep apnea [Fletcher, 2001]. Thus, the 
activation of the intrinsic angiotensin-generating system in the rat carotid body during 
stress of chronic hypoxia may be of great importance in terms of maintaining our body 
functions. This may be, in turn, of some clinical implications and relevance. 
In summary, the resultant data suggest that chronic hypoxia could upregulate the 
expression of angiotensinogen, Ang II receptors (predominantly the ATi receptor) and 
ACE in the carotid body, which might result in enhancing the carotid afferent nerve 
activity to Ang II stimulation. This could, in turn, increase the cardiorespiratory 
response and regulate the salt and water homeostasis during stress of chronic hypoxia. 
4.5 Time-dependent Changes of ACE Activity 
The localization and expression of the local RAS components by chronic 
hypoxia in rat carotid body have been demonstrated in the previous section. Results 
from RT-PCR showed there was an upregulation of ACE gene expression in rat carotid 
body by chronic hypoxia (Section 3.4.4). The expression of ACE in a time-dependent 
manner of 7，14 and 28 days of chronic hypoxia was further studied by specific assay of 
ACE activity using the internally quenched fluorogenic substrate. Results showed that 
there was a significant increase in the ACE activity of rat carotid body in both 7- and 14-
day hypoxic groups, whereas no significant difference was found in the 28-day hypoxic 
group when compared with their respective controls. In addition, captopril-inhibitable 
ACE activity in rat carotid body was also stimulated by chronic hypoxia in all treatments 
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(Section 3.5). As ACE is a critical enzyme for determining the conversion of 
decapeptide Ang I into the physiologically active octapeptide Ang II, the changes of 
ACE activity by chronic hypoxia should be of physiological and clinical relevance. 
A polymorphic DNA marker of the ACE gene, the insertion/deletion (I/D) 
polymorphism, has been associated with a number of pathological processes. 
Individuals who are homozygous for the D allele would have an increased risk of 
developing coronary artery disease and ventricular hypertrophy [Montgomery et al.， 
1997; Alvarez et al., 1998]. Compared to the I allele, the presence of the D allele has 
been associated with higher plasma ACE levels, as well as in ventricular tissue [Rigat et 
al.，1990; Danser et al., 1995]. A significantly higher frequency of the ACE I allele was 
found among elite rowers and high-altitudes mountaineers suggest that ACE I allele is 
associated with a better response to rigorous physical training [Montgomery et al , 1998; 
Gayagay et al.，1998; Alvarez et al., 2000]. The carotid body acts the first gate for 
detecting change in oxygen tension and composition. Its local RAS components 
together with the activity of ACE were upregulated by chronic hypoxia. There was a 
differential effect on the upregulation of the ACE activity in rat carotid body by chronic 
hypoxia in a time dependent manner. Results showed that there was a significant 
elevation effect on the ACE activity in the 7- and 14-day hypoxic rat carotid body while 
that of the 28-day hypoxia showed a statistically non-significant increase. Adaptation 
might explain and compensate this differential upregulatory effect of ACE activity 
during the period of chronic hypoxic. Nevertheless, ACE activity in the rat carotid body 
is elevated under the stress of chronic hypoxia. It has been reported that elevation of 
ACE activity in pulmonary artery smooth muscle cells by hypoxia may play an 
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important role in the development of hypoxic pulmonary hypertension [Yu and Ma; 
1998]. Therefore, the changes of ACE activity in rat carotid body by chronic hypoxia 
should be of physiological and clinical relevance. 
In summary, the present study has provided evidence for the presence of ACE in 
the rat carotid body. This critical enzyme for the locally generated RAS might be 
important for the regulation and function of carotid body's functions. The activity of the 
ACE in the carotid body was subjected to the activation by chronic hypoxia. The change 
of ACE activity in carotid body may have physiological and pathophysiological 
relevance in normal and disease states. 
4.6 Presence and Regulation of AT4 Receptor 
The RAS is closely involved in the regulation of the cardiovascular system and 
maintenance of salt and water homeostasis in the body. It is well known that Ang II acts 
primarily on the RAS, in both circulating and local levels, as the effector peptides, and 
binds to the ATi receptors to elicit biological effects. Besides, evidence for another 
biologically active peptides of the RAS, notably Ang (1-7) and Ang IV，are considered 
recently. Ang IV is a metabolite of Ang II containing six amino acid sequences. It binds 
to distinct AT4 receptors that have been localized in multiple tissues across various 
species, such as guinea pig and rat brain [Roberts et al, 1995], mouse brain [von Bohlen 
und Halbach and Albrecht, 2000] and rat kidney [Handa et al.，1998]. As there is 
abundance of Ang II receptors found in the carotid body which are functional and are 
subjected to modulation under stress of chronic hypoxia, it is of interest to demonstrate 
the existence of specific Ang IV receptors and to elucidate its regulation by chronic 
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hypoxia. 
Results from in-vitro autoradiography showed the existence of AT4 receptors in 
rat carotid body (Section 3.6.1), In conjugation with FITC-labeled Ang IV, the cellular 
localization of the AT4 receptors in rat carotid body was further demonstrated (Section 
3.6.2). In addition, the results show that the AT4 receptors were subject to upregulation 
by chronic hypoxia (Section 3.6.2; Fig. 3-27). Previous study showed that Ang IV does 
not bind to ATi or AT2 receptors with high affinity to elicit classical Ang II effects 
[Swanson et al., 1992]. It was then disregarded as an active angiotensin peptide of the 
RAS. However, more recent studies clearly demonstrated that Ang IV binds to a 
pharmacologically distinct angiotensin receptor, namely the AT* receptor, to produce 
unique biological effects [Swanson et al.，1992; Wright et al., 1993; Coleman et al , 
1998a]. Thus, the existence of the AT4 receptors in rat carotid body and its upregulation 
by chronic hypoxia may be of significance in some aspects. 
Results from in-vitro autoradiography showed the presence of AT4 receptor in rat 
carotid body (Section 3.6.1). The specificity of the AT4 receptor for Ang IV was 
confirmed by the demonstrations that ^^^I-Ang IV binding was not displaced in the 
presence of Sarile, an ATi and AT2 receptor ligand, while the displacement of '^^I-Ang 
IV binding was seen in the presence of excess Ang IV (Fig. 3-26). These results 
confirmed the existence of distinct Ang IV receptors in the rat carotid body. The 
presence of Ang IV specific binding site has been identified in several mammalian 
tissues and cells including the brain [Swanson et al.，1992; Kramar et al., 1998; Loufrani 
et al., 1999], heart membranes [Hanesworth et al., 1993], kidney [Handa et al., 1998; 
Handa et al., 1999], human collecting duct cells [Czekalski et al.，1996], culture bovine 
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aortic vascular smooth muscles cells [Hall et al, 1993] and lung endothelial cells [Hill-
Kapturczak et al, 1999; Patel et al.，1999]. The binding of Ang IV to the AT4 receptors 
has been reported to be involved in diverse functions, including blood flow regulation 
[Coleman et al.，1998b; Patel et al., 1998], learning and memory function [Wright et al., 
1995; Pederson et al., 1998], cell growth [Hall et al , 1995; Moeller et al., 1996; 
Pawlikowski and Kunert-Raadek, 1997] and anti-apoptosis [Kakinuma et al , 1997]. 
These findings support that AT4 receptor in the carotid body is likely to be 
physiologically important. 
Details of the Ang IV binding to its specific AT4 receptor cannot be examined by 
in-vitro autoradiography due to the small size of the carotid body and the coarse 
resolution of the autoradiographic image. By using the fluorescein-coupled Ang IV，the 
binding distribution of the AT4 site in the rat carotid body can be elucidated more 
precisely in cellular level (Section 3.6.2). Results clearly demonstrated the presence of 
the Ar4 receptors in the cellular localization of the carotid body. However, the exact 
localization of the AT4 receptors needs further confirmation. In addition, the results also 
demonstrated an upregulation of the expression of Ang IV receptor by chronic hypoxia 
in rat carotid body when compared with the normoxic control (Fig. 3-27). The 
specificity of the AT4 receptor for Ang IV was confirmed by demonstrating that 
fluorescein-coupled Ang IV binding was not displaced in the presence of Sarile, an ATi 
and AT2 receptor ligand. However, displacement of fluorescein-coupled Ang IV binding 
was observed in the presence of excess Ang IV. These results clearly demonstrated that 
in chronic hypoxia, the distinct Ang IV receptors, namely AT4 is upregulated in the rat 
carotid body, which may imply the functional and physiological relevance of the AT4 
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receptors of the carotid body. However, further experiments are needed to investigate 
the expression, localization, regulation and function of AT4 receptors in the carotid body. 
4.7 Conclusion 
There are currently few and certainly no conclusive descriptions of the RAS, the 
intrinsic RAS and their possible functions in the carotid body. The results of the present 
study establish a link between carotid body function in regulating the cardiorespiratory 
adaptation and RAS in the carotid body. There are functional expression of AT! 
receptors in the Type I cells of the rat carotid body. Ang II binding to the ATi receptors 
elevates activity of the Type I cells and the increased activity. In addition, 
Ang IV-AT4 receptors are found to be present in the rat carotid body as well. The 
changes of the RAS, the intrinsic angiotensin-generating RAS in the rat carotid body in 
response to chronic hypoxia, may enhance the carotid afferent nerve activity to Ang II 
stimulation. This could, in turn, increase the cardiorespiratory response and regulate the 
salt and water homeostasis during the stress of chronic hypoxia. The significance of the 
present study on the modulation of the RAS in the carotid body by chronic hypoxia may 
have clinical relevance to hypoxia-induced diseases, such as chronic obstructive 
pulmonary disease, congential heart disease, cystic fibrosis and obstructive sleep apnea. 
In summary, the findings from the present study includes: 
1. The expression of functional Ang II receptors in the Type I glomus cells of the 
rat carotid body. The binding of Ang II to Ang II receptors elevates [Ca^^], level 
of glomus cells and the carotid afferent activity that lead to an activation of the 
chemoreflex pathway. 
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2. Functional Ang II receptors in the Type I glomus cells of the rat carotid body are 
activated under the stress of chronic hypoxia. 
3. The existence of an intrinsic angiotensin-generating system in the rat carotid 
body probably via a renin independent biosynthetic pathway. 
4. This intrinsic angiotensin-generating system in the rat carotid body is also 
subjected to the regulation by chronic hypoxia. 
5. ACE is activated by chronic hypoxia and the effect of which on the activity of 
ACE in the rat carotid body is time-dependent. 
6. Ang IV receptors namely AT4 are likely to be present in the rat carotid body and 
are subjected to be regulated by chronic hypoxia. 
4.8 Future Works 
Due to the time and samples limitation, the activity of ACE of rat carotid was 
only measured in a time-course of 7-, 14- and 28-day hypoxic treatment. Interestingly, 
results revealed the differential effect of chronic hypoxia on the activity of ACE in rat 
carotid body of 7-, 14- and 28-day hypoxic treatment. There was a significant increase 
in the activity of ACE in the 7- and 14-day hypoxic rat carotid body when compared 
with their respective normoxic controls. Although the 28-day hypoxic rat carotid body 
showed an increase in the activity of ACE，the differences was not statistically 
significant. Since the time lag between the 14- and 28-day hypoxic treatments was 
comparatively long, it is better to test the effect of the 21-day hypoxic treatment on the 
activity of ACE in rat carotid body. Thus, in order to get a better picture and fuller 
understanding of the time-course effect of chronic hypoxia on ACE activity in rat carotid 
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body, the 21-day hypoxic treatment should be done. 
The resultant data of the in-vitro autoradiography and binding of fluorescein-
labeled Ang IV to rat carotid body need further improvements. Specific AT4 blocker 
such as divalinal-angiotensin IV may be a good choice to use in order to consolidate the 
exact identity of the AT4 receptor in rat carotid body. Although it is reasonable to 
conclude from the results that specific Ang IV receptors, namely AT4 receptors, should 
be present in rat carotid body and has been subjected to be upregulated under stress of 
chronic hypoxia, the possible functions of which in the carotid body is still unknown. In 
order to get a better understanding of the AT4 receptor in the carotid body, the expression, 
regulation and function await further investigation. However, the AT4 receptors have not 
been cloned yet; further investigations on this specific Ang IV receptor still encounter 
much technical problems and limitation. Extra efforts have to be put in the research of 
this newly emerging receptor in the carotid body. 
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